INTRODUCTION {#s1}
============

The budding yeast *Saccharomyces cerevisiae* is amenable to thorough molecular analyses and has relatively short and easily measurable chronological and replicative lifespans \[[@R1]--[@R7]\]. The use of this unicellular eukaryote with a sequenced genome as a model organism in aging research has provided fundamental insights on mechanisms of cellular aging \[[@R1], [@R2], [@R5], [@R6]\]. Studies in *S. cerevisiae* uncovered genes, signaling pathways and chemical compounds that postpone cellular aging not only in unicellular eukaryotes but also in evolutionarily diverse metazoans \[[@R1], [@R2], [@R5], [@R6], [@R8]--[@R18]\]. After being discovered in yeast, these genes, signaling pathways and chemical compounds appeared to extend healthy lifespan also in multicellular eukaryotes across phyla. It is believed therefore that the key aspects of the aging process and mechanisms of its delay by certain genetic, dietary and pharmacological interventions have been conserved during evolution \[[@R1], [@R6], [@R8], [@R17], [@R18]\].

Aging of unicellular eukaryotes and metazoans is an intricate biological phenomenon of an age-related functional deterioration \[[@R19], [@R20]\]. Such aging-associated functional decline impairs the regulation of a distinct set of cellular processes, thus making an organism more susceptible to disease and death \[[@R19], [@R20]\]. Cellular processes whose progressive dysregulation has been implicated in cellular and organismal aging of eukaryotes across phyla include cell cycle regulation, quiescent state maintenance by adult stem cells, cell growth, stress response, cellular signaling, apoptosis and other modes of regulated cell death (RCD), autophagy (including mitophagy), actin organization, nuclear DNA replication, chromatin assembly and maintenance, ribosome biogenesis and protein synthesis in the cytosol and mitochondria, protein folding, proteasomal degradation of misfolded proteins, oxidative and biosynthetic metabolic pathways in mitochondria, lipid and carbohydrate metabolism, NAD^+^ homeostasis, amino acid biosynthesis and degradation, and ammonium and amino acid uptake \[[@R19]--[@R35]\]. All these processes are controlled by a nutrient-sensing signaling network of longevity regulation that in evolutionarily distant metazoans integrates the insulin/insulin-like growth factor 1 (IGF-1) pathway, the AMP-dependent protein kinase (AMPK) pathway, the mammalian target of rapamycin complex 1 (mTORC1) pathway, the sirtuin-governed protein deacetylation module and the cAMP/protein kinase A (cAMP/PKA) pathway \[[@R1], [@R19], [@R21], [@R23], [@R36]--[@R39]\].

In chronologically aging *S. cerevisiae*, the nutrient-sensing signaling network of longevity regulation incorporates the TORC1, cAMP/PKA, Pkb-activating kinase homolog (PKH1/2), sucrose non-fermenting (SNF1) and autophagy (ATG) pathways \[[@R1], [@R5], [@R11], [@R32], [@R40]--[@R51]\]. The network also integrates the serine/threonine-specific protein kinases Sch9 (which is stimulated by the TORC1 and PKH1/2 pathways) and Rim15 (which is inhibited by the TORC1, PKA and PKH1/2 pathways) \[[@R1], [@R5], [@R11], [@R32], [@R40]--[@R51]\]. Certain chemical compounds of bacterial, fungal, plant or mammalian origin can delay the chronological aging and extend longevity of *S. cerevisiae* because they regulate the flow of information along these convergent, divergent and multiply branched signaling pathways and protein kinases. Such aging-delaying chemicals include resveratrol, rapamycin, caffeine, spermidine, myriocin, methionine sulfoxide, lithocholic acid and cryptotanshinone \[[@R1], [@R2], [@R11], [@R13], [@R44], [@R48], [@R52]--[@R54]\].

In search for novel chemical compounds that can delay aging and prolong longevity of chronologically aging yeast, we have recently conducted a screen of many extracts from plants used in traditional Chinese herbal medicines or in the Mediterranean diet \[[@R55]\]. Our screen revealed several aging-delaying and longevity-extending plant extracts (PEs). One of them is PE21, an extract from the white willow *Salix alba* \[[@R55]\]. PE21 delays yeast chronological aging much more efficiently than any of the previously known pharmacological interventions \[[@R55]\]. We demonstrated that PE21 slows aging by inhibiting a form of the pro-aging protein kinase Sch9 that is stimulated by the pro-aging PKH1/2 signaling pathway \[[@R56]\]. Such PE21-dependent inhibition of Sch9 coincides with changes in several cellular processes known to regulate longevity of *S. cerevisiae* \[[@R55]\]. In this study, we investigated mechanisms through which PE21 delays chronological aging of *S. cerevisiae* and extends its longevity. We show that these mechanisms involve a specific remodeling of the cellular lipidome, a stimulation of the unfolded protein response in the endoplasmic reticulum (ER), and an activation of catabolic and anabolic processes in mitochondria.

RESULTS {#s2}
=======

An overview of longevity-defining and geroprotective cellular processes affected by PE21 {#s2_1}
----------------------------------------------------------------------------------------

Our previous study has revealed that PE21 extends longevity of chronologically aging yeast cultured in a synthetic minimal medium initially containing 2% (w/v) glucose \[[@R55]\]. Yeast cells cultured on 2% glucose are not limited in calorie supply or intake and, thus, undergo chronological aging under so-called non-caloric restriction (non-CR) conditions \[[@R1], [@R2], [@R6]\]. Non-CR conditions are known to speed up chronological aging in yeast \[[@R1], [@R2], [@R6]\]. We also reported that PE21 prolongs yeast chronological lifespan (CLS) of yeast cultured under CR conditions on 0.5% (w/v) glucose significantly less efficiently than it does under non-CR conditions \[[@R55]\]. CR conditions have been shown to slow down yeast chronological aging \[[@R1], [@R2], [@R6]\]. Because the longevity-extending efficiency of PE21 under non-CR conditions significantly exceeds that under CR conditions, we concluded that PE21 is a CR-mimetic \[[@R55]\]. CR mimetics are pharmacological interventions that under non-CR conditions target the same set of longevity-defining cellular processes as CR, thus delaying aging even if calorie supply and intake are not limited \[[@R57]--[@R59]\].

In yeast cultured under non-CR conditions on 2% glucose, PE21 is a geroprotector that elicits a hormetic stress response and imposes changes in certain cellular processes \[[@R55]\]. Specifically, PE21 alters the following aspects of mitochondrial functionality: 1) it significantly increases the rate of coupled mitochondrial respiration during post-diauxic (PD) growth phase (which occurs on day 2 of culturing) and stationary (ST) growth phase (which occurs after 2 days of culturing); 2) it prolongs mitochondrial functionality by preventing an age-related decline in mitochondrial membrane potential during PD and ST growth phases; and 3) it alters the pattern of age-related changes in intracellular reactive oxygen species (ROS) that are created mainly as by-products of mitochondrial respiration \[[@R60], [@R61]\]; such PE21-dependent pattern alterations consist in decreasing ROS concentration during logarithmic (L) growth phase on day 1 of culturing and during PD growth phase, and in lowering the extent to which ROS concentration declines during ST phase \[[@R55]\]. Furthermore, PE21 significantly decreases the extent of oxidative damage to cellular proteins and membrane lipids during ST phase \[[@R55]\]. Moreover, PE21 substantially lowers the frequencies of spontaneous point mutations in the DNA within the nucleus and mitochondria during ST phase, likely because PE21 decreases the extent of oxidative damage to nuclear and mitochondrial DNA \[[@R55]\]. PE21 also considerably increases cell resistance to chronic oxidative and thermal stresses during ST phase \[[@R55]\]. In addition, PE21 promotes a rapid age-related degradation of neutral lipids (i. e. triacylglycerols \[TAG\] and ergosterols) stored in lipid droplets (LD) during PD and ST phases \[[@R55]\].

PE21 alters the relative levels of different lipid classes in an age-related manner {#s2_2}
-----------------------------------------------------------------------------------

The maintenance of lipid homeostasis is indispensable for healthy aging in yeast and metazoans because lipid metabolism and transport are essential contributors to the aging process in unicellular and multicellular eukaryotes \[[@R32], [@R62]--[@R115]\]. Since PE21 promotes a rapid age-related degradation of neutral lipids deposited in LD \[[@R55]\], we sought to determine whether PE21 may affect the abundance of other lipid classes in chronologically aging yeast under non-CR conditions. We therefore used quantitative mass spectrometry to compare the cellular lipidome of wild-type (WT) yeast cultured under non-CR conditions on 2% glucose with 0.1% (w/v) PE21 to the cellular lipidome of WT cells cultured on 2% glucose without PE21. If PE21 is used at the final concentration of 0.1% with ethanol being utilized as a vehicle at the final concentration of 0.5% (v/v), this PE exhibits the highest efficacy of yeast CLS extension under non-CR conditions on 2% glucose; this is in comparison to WT cells subjected to ethanol-mock treatment by being cultured in growth medium initially containing 2% glucose and 0.5% ethanol \[[@R55]\]. Cells for lipid extraction and mass spectrometric lipidomics were recovered on days 1, 2, 3 and 4 of culturing on 2% glucose because only 11.7 ± 4.4% (*n =* 35) of WT cells cultured without PE21 were viable after 4 days of such culturing \[[@R55]\]. In contrast, 95.6 ± 3.1% (*n =* 35) of WT cells cultured with 0.1% PE21 were viable after 4 days of culturing on 2% glucose \[[@R55]\].

PE21 exhibited differential effects on the relative levels of different lipid classes calculated as mol% of all lipids; moreover, these effects of PE21 were age-related. Indeed, we found that 1) PE21 elicits a significant decline in the relative levels of TAG, free (i. e. unesterified) fatty acids (FFA) and the signature mitochondrial membrane lipid cardiolipin (CL); 2) the extent to which PE21 lowers the relative levels of TAG, FFA and CL is gradually increased with the chronological age of WT cells; 3) PE21 causes a significant decline in the relative level of CL in WT cells recovered at L phase (on day 1 of culturing), PD phase (on day 2 of culturing) and ST phase (on days 3 and 4 of culturing); and 4) PE21 significantly decreases the relative levels of TAG and FFA only in WT cells recovered at PD or ST phase of culturing ([Figure 1A](#F1){ref-type="fig"}, [1B](#F1){ref-type="fig"} and [1H](#F1){ref-type="fig"}). Our mass spectrometric identification and quantitation of cellular lipids also revealed that 1) PE21 causes a significant rise in the relative levels of all membrane glycerophospholipids, including phosphatidic acid (PA), phosphatidylserine (PS), phosphatidylethanolamine (PE), phosphatidylcholine (PC) and phosphatidylinositol (PI); 2) the extent of such effect of PE21 on the relative levels of PA, PS, PE, PC and PI is gradually increased with the chronological age of WT cells; 3) PE21 elicits a significant rise in the relative level of PE in WT cells recovered at L phase (on day 1 of culturing), PD phase (on day 2 of culturing) and ST phase (on days 3 and 4 of culturing); 4) PE21 significantly raises the relative levels of PA, PS and PI only in WT cells recovered at PD or ST phase of culturing; and 5) PE21 causes a significant increase in the relative level of PC only in WT cells recovered at ST phase on day 4 of culturing ([Figure 1C](#F1){ref-type="fig"}--[1G](#F1){ref-type="fig"}).

![PE21 exhibits age-dependent differential effects on the relative levels of different lipid classes.\
Cells of the wild-type (WT) strain were grown in the synthetic minimal YNB medium (0.67% \[w/v\] yeast nitrogen base without amino acids) initially containing 2% (w/v) glucose, in the presence of 0.1% (w/v) PE21 (ethanol was used as a vehicle at the final concentration of 0.5% \[v/v\]) or in its absence (cells were subjected to ethanol-mock treatment). Cells were recovered on days 1, 2, 3 and 4 of culturing. Extraction of cellular lipids and mass spectrometric identification and quantitation of different lipid classes were carried out as described in Materials and Based on these data, the relative levels of triacylglycerols \[TAG\] (**A**), free fatty acids \[FFA\] (**B**), phosphatidic acid \[PA\] (**C**), phosphatidylserine \[PS\] (**D**), phosphatidylethanolamine \[PE\] (**E**), phosphatidylcholine \[PC\] (**F**), phosphatidylinositol \[PI\] (**G**) and cardiolipin \[CL\] (**H**) were calculated as mol% of all lipid classes in cells recovered on day 1, 2, 3 or 4 of culturing. Data are presented as means ± SEM (*n =*4; ^\*^ *p \<*0.05; ^\*\*^ *p \<*0.01; ^\*\*\*^ *p \<*0.001; ns, not significant). Abbreviations: Logarithmic (L), post-diauxic (PD) or stationary (ST) growth phase.](oncotarget-10-5780-g001){#F1}

In sum, these findings indicate that PE21 causes significant age-related changes in the relative levels of different lipid classes in WT cells under non-CR conditions.

PE21 causes a specific remodeling of lipid metabolism and transport in chronologically aging yeast, likely by redirecting the flows of FFA and PA into different classes of lipids {#s2_3}
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Our findings that PE21 alters the relative levels of FFA, the neutral lipid TAG, the signature mitochondrial membrane lipid CL and all classes of membrane glycerophospholipids suggest that PE21 may instigate a specific remodeling of lipid metabolism and transport in several organelles of chronologically aging yeast. The metabolic and interorganellar transport processes that define the concentrations of all these lipid classes in yeast cells are well known \[[@R32], [@R116]--[@R149]\]. These processes are catalyzed by enzymes that reside in the cytosol, ER, mitochondria, LD and peroxisomes ([Supplementary Figure 1](#SD1){ref-type="supplementary-material"}) \[[@R32], [@R116]--[@R149]\].

Glucose, the only carbon source exogenously added to yeast cultures in this study, is initially converted to pyruvate via the glycolytic pathway in the cytosol ([Supplementary Figure 1](#SD1){ref-type="supplementary-material"}). The glycolytically produced pyruvate is then used for the synthesis of acetyl-CoA (Ac-CoA) through three consecutive reactions catalyzed by the cytosolic pyruvate decarboxylase isozymes Pdc1, Pdc5 and Pdc6, aldehyde dehydrogenases Ald2-Ald6, and Ac-CoA synthetase isoforms Acs1 and Acs2 ([Supplementary Figure 1](#SD1){ref-type="supplementary-material"}). After being synthesized in the cytosol, Ac-CoA is used as a substrate for the formation of FFA by the cytosolic Ac-CoA carboxylase Acc1 and FA synthase complex Fas1/Fas2 ([Supplementary Figure 1](#SD1){ref-type="supplementary-material"}). The cytosolic pool of Ac-CoA used for the formation of FFA by Acc1 and Fas1/Fas2 is also created as the product of peroxisomal β-oxidation of FFA in Fox1-, Fox2- and Fox3-dependent chemical reactions ([Supplementary Figure 1](#SD1){ref-type="supplementary-material"}). Other sources of FFA are the hydrolysis of TAG by the lipases Tgl1, Tgl3, Tgl4 and Tgl5 confined to LD ([Supplementary Figure 1](#SD1){ref-type="supplementary-material"}), as well as the lipolytic degradation of TAG-derived diacylglycerols (DAG) and monoacylglycerols (MAG) by the lipases Tgl3 and Yju3 (respectively) in LD ([Supplementary Figure 1](#SD1){ref-type="supplementary-material"}).

After FFA are formed from Ac-CoA, TAG, DAG or MAG, they are activated to yield fatty acyl-CoA esters (FA-CoA) in reactions catalyzed by the long chain acyl-CoA synthetases Faa1, Faa4 and Fat1 in the ER ([Supplementary Figure 1](#SD1){ref-type="supplementary-material"}). These FA-CoA are then used for the *de novo* synthesis of TAG, glycerophospholipids and CL by enzymes confined to the ER and mitochondria ([Supplementary Figure 1](#SD1){ref-type="supplementary-material"}). This *de novo* synthesis begins in the ER where the glycerol-3-phosphate/dihydroxyacetone phosphate acyltransferases Sct1 and Gpt2 catalyze the formation of lysophosphatidic acid (LPA) or acyl-dihydroxyacetone phosphate (ADHAP) from FA-CoA and glycerol-3-phosphate or DHAP, respectively ([Supplementary Figure 1](#SD1){ref-type="supplementary-material"}). An Ayr1-driven reaction converts ADHAP to LPA ([Supplementary Figure 1](#SD1){ref-type="supplementary-material"}). The LPA formed in an Sct1-, Gpt2- and Ayr1-dependent manner is then converted to PA in an acyl CoA-dependent reaction catalyzed by the LPA acyl-transferases Slc1, Slc4, Loa1 and Ale1 ([Supplementary Figure 1](#SD1){ref-type="supplementary-material"}). A Cds1-driven reaction converts PA to cytidine diphosphate (CDP)-DAG, which is then used as a common precursor for the Cho1-dependent synthesis of PS in the ER, transfer of PS from the ER to the outer mitochondrial membrane (OMM) via mitochondria-ER contact sites, Ups2-driven transport of PS from the OMM to the inner mitochondrial membrane (IMM) via the intermediate space (IMS), Psd1-dependent synthesis of PE in the IMM, transfer of PE from the IMM across the IMS to the OMM and then to the ER via mitochondria-ER contact sites, Pis1-dependent synthesis of PI in the ER, and Cho2- and Opi3-dependent synthesis of PC in the ER ([Supplementary Figure 1](#SD1){ref-type="supplementary-material"}). PA can also be converted to DAG in a reaction catalyzed by the PA phosphatases Pah1, App1, Dpp1 and Lpp1 in the ER ([Supplementary Figure 1](#SD1){ref-type="supplementary-material"}). The ensuing acylation of DAG to TAG occurs in an FA-CoA-dependent reaction driven by Dga1, Are1 and Are2, and in a PE- and PC-dependent reaction catalyzed by Lro1 ([Supplementary Figure 1](#SD1){ref-type="supplementary-material"}). After the *de novo* synthesis of TAG in the ER, TAG are deposited in LD ([Supplementary Figure 1](#SD1){ref-type="supplementary-material"}). In addition, PA can move from the ER to the OMM via mitochondria-ER contact sites and then from the OMM to the IMM in an Ups1-dependent transfer reaction inhibited by CL ([Supplementary Figure 1](#SD1){ref-type="supplementary-material"}). After the ER-derived PA is delivered to the IMM, it is converted into CDP-DAG, phosphatidylglycerol (PG), CL and monolysocardiolipin (MLCL) in reactions catalyzed by Tam41, Pgs1, Gep4, Crd1, Cld1 and Taz1 ([Supplementary Figure 1](#SD1){ref-type="supplementary-material"}).

Considering the intensive knowledge of lipid metabolism and interorganellar transport in yeast cells, our data on PE21-dependent changes in the cellular lipidome indicate that PE21 redirects the flows of FFA and PA into different classes of lipids to cause a specific reorganization of lipid metabolism and transport in chronologically aging yeast. A model of such PE21-driven reorganization of lipid metabolism and transport in yeast cells is schematically depicted in [Supplementary Figure 2](#SD1){ref-type="supplementary-material"}. In this model, PE21 alters the efficiencies with which FFA and PA are incorporated into the synthesis of other lipids as follows: 1) it intensifies FFA incorporation into PA, thus lowering FFA concentration and increasing PA concentration; 2) it decreases the efficiency of PA flow into the synthesis of TAG in the ER, thereby lowering TAG concentration, decreasing the concentration of FFA derived from TAG lipolysis and rising PA concentration; 3) it intensifies PA entry into the synthesis of glycerophospholipids in the ER and mitochondria, thus increasing the concentrations of PS, PE, PC and PI in the ER and rising PS and PE concentrations in mitochondria; and 4) it lowers the efficiency of PA transport from the ER to the OMM and then to the IMM, thereby decreasing the concentrations of PA-derived CL in mitochondrial membranes ([Supplementary Figure 2](#SD1){ref-type="supplementary-material"}).

Our hypothesis on three possible mechanisms through which PE21 may delay yeast chronological aging and extend yeast longevity {#s2_4}
-----------------------------------------------------------------------------------------------------------------------------

Based on the abilities of PE21 to cause a specific remodeling of lipid metabolism and transport (the present study) and to impose changes in certain cellular processes \[[@R55]\] within yeast cultured under non-CR conditions, we put forward a hypothesis that there may be at least three different mechanisms by which PE21 delays yeast chronological aging and extends yeast CLS. These possible mechanisms are outlined below and schematically depicted in [Figure 2](#F2){ref-type="fig"}.

![Possible mechanisms through which PE21 may delay yeast chronological aging.\
Arrows next to the names of lipid classes denote those of them whose concentrations are increased (red arrows) or decreased (blue arrows) in yeast cells cultured in the presence of PE21. The thickness of black arrows is proportional to the efficiency with which free fatty acids (FFA) and phosphatidic acid (PA) are included into the synthesis of other lipid classes. There may be at least three different mechanisms by which PE21 delays yeast chronological aging. These mechanisms are numbered. Mechanism 1: PE21 maintains FFA concentration below a toxic threshold, thus weakening an age-related form of FFA-driven liponecrotic regulated cell death (RCD). Mechanism 2: PE21 suppresses TAG formation and promotes glycerophospholipid synthesis in the endoplasmic reticulum (ER), thereby activating the unfolded protein response in the ER (UPR^ER^). Mechanism 3: PE21 increases phosphatidylserine (PS) and phosphatidylethanolamine (PE) concentrations and lower cardiolipin (CL) concentration in mitochondria, thus altering mitochondrial functionality. See text for more details. Other abbreviations: CDP, cytidine diphosphate; DAG, diacylglycerol; IMM, inner mitochondrial membrane; MLCL, monolysocardiolipin; OMM, outer mitochondrial membrane; PC, phosphatidylcholine; PG, phosphatidylglycerol; PI, phosphatidylinositol; TAG, triacylglycerol.](oncotarget-10-5780-g002){#F2}

First mechanism: the present study demonstrates that PE21 lowers FFA concentration, likely because it intensifies FFA incorporation into PA ([Figure 1B](#F1){ref-type="fig"} and [1C](#F1){ref-type="fig"}; [Supplementary Figure 2](#SD1){ref-type="supplementary-material"}). The present study also reveals that PE21 decreases the concentration of TAG ([Figure 1A](#F1){ref-type="fig"}; [Supplementary Figure 2](#SD1){ref-type="supplementary-material"}), the major form of FFA storage \[[@R22], [@R32], [@R120], [@R121], [@R126], [@R129], [@R135], [@R136], [@R146]\]; this may further contribute to the PE21-driven decline in FFA concentration because the lipolysis of TAG in chronologically aging yeast is known to be a source of the bulk quantities of FFA \[[@R22], [@R32], [@R120], [@R121], [@R126], [@R129], [@R135], [@R136], [@R146]\]. An exposure of yeast cells to exogenous FFA has been shown to promote a "liponecrotic" form of RCD in an age-related manner \[[@R32], [@R52], [@R137], [@R150]--[@R155]\]. Such exposure elicits the incorporation of FFA into membrane glycerophospholipids and TAG, thereby reorganizing lipid metabolism and transfer in the ER, mitochondria, LD and the plasma membrane (PM) \[[@R32], [@R52], [@R137], [@R150]--[@R155]\]. Certain aspects of the FFA-driven reorganization of lipid metabolism and transfer are essential contributors to the commitment of yeast to liponecrosis or to the execution of this mode of RCD \[[@R32], [@R52], [@R137], [@R150]--[@R155]\]. These aspects include the following: 1) an excessive rise in PM permeability for small molecules; 2) a decline in mitochondrial functionality; 3) an excessive production of ROS in mitochondria; 4) an oxidative damage to various cellular organelles, which promotes massive autophagic degradation of these organelles; and 5) an oxidative impairment of the bulk quantities of cellular proteins, which disturbs cellular proteostasis by eliciting a build-up of dysfunctional, unfolded and aggregated proteins in the cytosol \[[@R32], [@R52], [@R137], [@R150]--[@R155]\]. Because the accumulation of excessive quantities of FFA actively increases the risk of liponecrotic cell death and decreases the chance of cell survival throughout chronological lifespan, FFA accumulation in quantities exceeding a toxic threshold shortens longevity of chronologically aging yeast \[[@R32], [@R52], [@R137], [@R150]--[@R155]\]. It needs to be emphasized that PE21 not only extends yeast longevity but also affects those aspects of the FFA-driven reorganization of the cellular lipidome that contribute to the commitment or execution of liponecrotic RCD \[[@R55]\]. Indeed, PE21 slows an age-related decline in mitochondrial functionality, alters the pattern of age-related changes in mitochondrially produced ROS and decreases the extent of oxidative damage to cellular proteins \[[@R55]\]. Taken together, these findings suggest that the first mechanism through which PE21 may delay yeast chronological aging and extend yeast CLS consists in the ability of PE21 to lower FFA concentration, thus maintaining FFA concentration below the toxic threshold and weakening an age-related form of FFA-driven liponecrotic RCD ([Figure 2](#F2){ref-type="fig"}).

Second mechanism: the present study shows that PE21 causes significant perturbations in the relative levels of membrane lipids within the ER by weakening TAG formation and strengthening glycerophospholipid synthesis in this organelle ([Figure 1B](#F1){ref-type="fig"}--[1G](#F1){ref-type="fig"}; [Supplementary Figure 2](#SD1){ref-type="supplementary-material"}). Such perturbations in the relative levels of ER membrane lipids are known to stimulate the unfolded protein response in the ER (UPR^ER^) in yeast and metazoans, either by weakening the folding of ER proteins and eliciting their accumulation in the ER or without causing unfolded protein stress within this organelle \[[@R156]--[@R179]\]. When activated, the UPR^ER^ system allows to reinstate protein and lipid homeostasis in the ER. Such reinstatement is achieved because the activated UPR^ER^ system slows protein synthesis in the ER, stimulates *N*-linked protein glycosylation of ER proteins, promotes a refolding of improperly folded ER proteins, directs other improperly folded proteins accumulated in the ER for the removal by ER-associated degradation or autophagy, enhances vesicular traffic from the ER throughout the secretory pathway, and activates the synthesis of membrane lipids in the ER \[[@R176], [@R180]--[@R186]\]. A body of evidence indicates that the UPR^ER^ system of protein and lipid homeostasis restoration within the ER is indispensable for preventing an age-related decline in protein and lipid homeostasis maintenance within the entire cell; this is because the UPR^ER^ system slows protein synthesis, weakens oxidative and thermal protein damage, promotes protein folding and vesicular transport, stimulates autophagic and proteasomal degradation of improperly folded proteins, and controls lipid metabolism within the entire cell \[[@R161], [@R167], [@R170], [@R174]--[@R176], [@R178], [@R181], [@R185]--[@R202]\]. As such, the UPR^ER^ system is commonly perceived as a process that is essential for delaying cellular and organismal aging and slowing down the onset of aging-associated disorders \[[@R160], [@R163], [@R167], [@R181], [@R185]--[@R202]\]. Of note, the ability of PE21 to extend longevity of chronologically aging yeast coincides with its abilities to decrease the extent of oxidative damage to cellular proteins, lipids and nucleic acids, and to increase cell resistance to chronic oxidative stress \[[@R55]\]. In sum, the above findings suggest that the second mechanism by which PE21 may delay yeast chronological aging and extend yeast CLS consists in its ability to alter the ER lipidome, thus activating UPR^ER^ ([Figure 2](#F2){ref-type="fig"}). Our hypothesis posits that such PE21-driven activation of the UPR^ER^ system may be responsible for the observed abilities of PE21 to slow down an age-related decline in protein, lipid and nucleic acid homeostasis and to decelerate an aging-associated weakening of cell resistance to oxidative and thermal stresses \[[@R55]\].

Third mechanism: the present study reveals that PE21 alters the membrane lipidome of mitochondria by rising PS and PE concentrations and lowering CL concentration in these organelles ([Figure 1D](#F1){ref-type="fig"}, [1E](#F1){ref-type="fig"} and [1H](#F1){ref-type="fig"}; [Supplementary Figure 2](#SD1){ref-type="supplementary-material"}). A body of evidence supports the notion that the composition of mitochondrial membrane lipids is an essential contributor to mitochondrial functionality and as such, the mitochondrial membrane lipidome defines longevity of yeast and multicellular eukaryotes \[[@R32], [@R34], [@R77], [@R87], [@R97], [@R103], [@R104], [@R108], [@R203]--[@R209]\]. Notable, PE21 not only prolongs yeast longevity but also amends the pattern of age-related changes in several key aspects of mitochondrial functionality, including mitochondrial respiration, mitochondrial membrane potential and mitochondrial ROS production \[[@R55]\]. These findings suggest that the third mechanism by which PE21 may delay yeast chronological aging and extend yeast longevity consists in its ability to reorganize processes confined to mitochondria, thus altering mitochondrial functionality ([Figure 2](#F2){ref-type="fig"}).

In a series of experiments outlined below, we assessed how each of the three mechanisms contributes to the extension of yeast CLS by PE21.

PE21 extends longevity of chronologically aging yeast in part because it delays the age-related onset of FFA-dependent liponecrotic RCD {#s2_5}
---------------------------------------------------------------------------------------------------------------------------------------

Our hypothesis on the first mechanism through which PE21 may extend longevity of chronologically aging yeast predicts that mutations capable of increasing cellular FFA concentration will weaken the longevity-extending efficiency of PE21 ([Figure 2](#F2){ref-type="fig"}). To test this prediction, we examined how a single-gene-deletion mutation eliminating the Faa1, Faa4, Ale1 or Slc1 protein affects the efficiency of yeast CLS extension by PE21 and how it influences the cellular concentration of FFA. Faa1, Faa4, Ale1 and Slc1 catalyze reactions of the incorporation of FFA into PA within the ER ([Supplementary Figure 1](#SD1){ref-type="supplementary-material"}) \[[@R32], [@R122], [@R125], [@R133]\]. A single-gene-deletion mutation eliminating either of these four proteins is known to increase the concentration of FFA in yeast cultured in the nutrient-rich YP (1% yeast extract and 2% peptone) medium initially containing 2% glucose \[[@R210]--[@R214]\]. It was unknown however if any of these mutations has a similar effect on FFA concentration in yeast cultured in a synthetic minimal YNB medium (0.67% Yeast Nitrogen Base) initially containing 2% glucose, i. e. under culturing conditions used in the present study. We found that the *faa1Δ*, *faa4Δ*, *ale1Δ* and *slc1Δ* mutations cause a significant decline in the efficiency with which PE21 can prolong both the mean and maximum CLS of *S. cerevisiae*, although the extent of such decline was different for each of these single-gene-deletion mutations ([Figure 3A](#F3){ref-type="fig"}--[3D](#F3){ref-type="fig"} and [3F](#F3){ref-type="fig"}--[3I](#F3){ref-type="fig"} for *faa1Δ* and *faa4Δ*, respectively; [Figure 4A](#F4){ref-type="fig"}--[4D](#F4){ref-type="fig"} and [4F](#F4){ref-type="fig"}--[4I](#F4){ref-type="fig"} for *ale11Δ* and *slc1Δ*, respectively). We also revealed that all these single-gene-deletion mutations substantially increase cellular FFA concentration; however, the extent of such rise in cellular FFA concentration was different for each of them ([Figure 3E](#F3){ref-type="fig"} and [3J](#F3){ref-type="fig"} for *faa1Δ* and *faa4Δ*, respectively; [Figure 4E](#F4){ref-type="fig"} and [4J](#F4){ref-type="fig"} for *ale11Δ* and *slc1Δ*, respectively). In sum, the above findings support our prediction that mutations increasing cellular FFA concentration can weaken the efficiency with which PE21 prolongs longevity of chronologically aging yeast.

![The *faa1Δ* and *faa4Δ* mutations eliminate enzymes involved in the incorporation of FFA into PA.\
These mutations increase cellular FFA concentration and decrease the efficiency with which PE21 prolongs yeast chronological lifespan (CLS). WT cells and mutant cells carrying a single-gene-deletion mutation eliminating either Faa1 or Faa4 were cultured in the synthetic minimal YNB medium initially containing 2% glucose with 0.1% PE21 or without it. (**A**, **F**) Survival curves of the chronologically aging WT and *faa1Δ* (**A**) or WT and *faa4Δ* (**F**) strains are shown. Data are presented as means ± SEM (*n =*3). Data for the WT strain cultured with or without PE21 are replicated in the graphs of (**A**) and (**F**) and [Figures 4A](#F4){ref-type="fig"}, [4F](#F4){ref-type="fig"}, [5A](#F5){ref-type="fig"}, [5F](#F5){ref-type="fig"}, [6A](#F6){ref-type="fig"}, [6F](#F6){ref-type="fig"}, [10A](#F10){ref-type="fig"}--[10D](#F10){ref-type="fig"}, [11A](#F11){ref-type="fig"}--[11C](#F11){ref-type="fig"}, [14A](#F14){ref-type="fig"}--[14D](#F14){ref-type="fig"}, [15A](#F15){ref-type="fig"}--[15D](#F15){ref-type="fig"}. (**B**, **G**) *p* Values for different pairs of survival curves of the WT and *faa1Δ* (**B**) or WT and *faa4Δ* (**G**) strains cultured with or without PE21. Survival curves shown in A or F (respectively) were compared. Two survival curves were considered statistically different if the *p* value was less than 0.05. The *p* values for comparing pairs of survival curves using the logrank test were calculated as described in Materials and Methods. The *p* values displayed on a yellow color background indicate that PE21 statistically significantly prolongs the CLS of the WT, *faa1Δ* (**B**) and *faa4Δ* (**G**) strains. The *p* values displayed on a blue color background indicate that PE21 prolongs the CLS of the *faa1Δ* (**B**) and *faa4Δ* (**G**) strains to a lower extent than that of the WT strain. (**C**, **D**, **H**, **I**) Survival curves shown in (**A**, **F**) were used to calculate the fold of increase of the mean (**C**, **H**) and maximum (**D**, **I**) CLS by PE21 for the WT and *faa1Δ* (**C**, **D**) and WT and *faa4Δ* (**H**, **I**) strains. Data are presented as means ± SEM (*n =*3; ^\*^ *p \<*0.05; ^\*\*^ *p \<*0.01). (**E**, **J**) The maximum concentration of free fatty acids (FFA), which was observed in WT and *faa1Δ* (**E**) or WT and *faa4Δ* (**J**) cells recovered on day 3 of culturing with PE21, is shown. Data are presented as means ± SEM (*n =*4; ^\*^ *p \<*0.05; ^\*\*^ *p \<*0.01).](oncotarget-10-5780-g003){#F3}

In our hypothesis on the first mechanism, mutations that decrease cellular FFA concentration are expected to enhance the longevity-extending efficiency of PE21 ([Figure 2](#F2){ref-type="fig"}). We therefore investigated how a single-gene-deletion mutation eliminating the Tgl1, Tgl3, Tgl4 or Tgl5 protein influences the efficiency of yeast CLS extension by PE21 and how it affects the cellular concentration of FFA. Tgl1, Tgl3, Tgl4 and Tgl5 catalyze reactions of the formation of FFA as products of TAG lipolysis in LD ([Supplementary Figure 1](#SD1){ref-type="supplementary-material"}) \[[@R22], [@R32], [@R116], [@R118], [@R120], [@R121], [@R134]--[@R136]\]. A knock-out mutation removing either of these four proteins has been shown to increase the concentration of FFA in yeast cultured in the nutrient-rich YP medium initially supplemented with 2% glucose \[[@R215]--[@R217]\]. However, it remained unknown if any of these mutations has a similar effect on FFA concentration in yeast cultured in a synthetic minimal YNB medium initially supplemented with 2% glucose, i. e. under conditions yeast were cultured in the present study. We found that the *tgl1Δ*, *tgl3Δ*, *tgl4Δ* and *tgl5Δ* mutations increase the efficiency with which PE21 can extend yeast CLS and that the extent of such increase is different for each of these mutations ([Figure 5A](#F5){ref-type="fig"}--[5D](#F5){ref-type="fig"} and [5F](#F5){ref-type="fig"}--[5I](#F5){ref-type="fig"} for *tgl1Δ* and *tgl3Δ*, respectively; [Figure 6A](#F6){ref-type="fig"}--[6D](#F6){ref-type="fig"} and [6F](#F6){ref-type="fig"}--[6I](#F6){ref-type="fig"} for *tgl4Δ* and *tgl5Δ*, respectively). We also noted that all these mutations decrease cellular FFA concentration and that the extent of such decrease is different for each of them ([Figure 5E](#F5){ref-type="fig"} and [5J](#F5){ref-type="fig"} for *tgl1Δ* and *tgl3Δ*, respectively; [Figure 6E](#F6){ref-type="fig"} and [6J](#F6){ref-type="fig"} for *tgl3Δ* and *tgl4Δ*, respectively). Together, these data confirm that mutations decreasing cellular FFA concentration can enhance the longevity-extending efficiency of PE21.

![The *ale1Δ* and *slc1Δ* mutations eliminate enzymes involved in the incorporation of FFA into PA.\
These mutations increase cellular FFA concentration and decrease the efficiency with which PE21 prolongs yeast CLS. WT cells and mutant cells carrying a single-gene-deletion mutation eliminating either Ale1 or Slc1 were cultured in the synthetic minimal YNB medium initially containing 2% glucose with 0.1% PE21 or without it. (**A**, **F**) Survival curves of the chronologically aging WT and *ale1Δ* (**A**) or WT and *slc1Δ* (**F**) strains are shown. Data are presented as means ± SEM (*n =*3). Data for the WT strain cultured with or without PE21 are replicated in the graphs of (**A**) and (**F**) and [Figures 3A](#F3){ref-type="fig"}, [3F](#F3){ref-type="fig"}, [5A](#F5){ref-type="fig"}, [5F](#F5){ref-type="fig"}, [6A](#F6){ref-type="fig"}, [6F](#F6){ref-type="fig"}, [10A](#F10){ref-type="fig"}--[10D](#F10){ref-type="fig"}, [11A](#F11){ref-type="fig"}--[11C](#F11){ref-type="fig"}, [14A](#F14){ref-type="fig"}--[14D](#F14){ref-type="fig"}, [15A](#F15){ref-type="fig"}--[15D](#F15){ref-type="fig"}. (**B**, **G**) *p* Values for different pairs of survival curves of the WT and *ale1Δ* (**B**) or WT and *slc1Δ* (**G**) strains cultured with or without PE21. Survival curves shown in (**A)** or (**F)** (respectively) were compared. Two survival curves were considered statistically different if the *p* value was less than 0.05. The *p* values for comparing pairs of survival curves using the logrank test were calculated as described in Materials and Methods. The *p* values displayed on a yellow color background indicate that PE21 statistically significantly prolongs the CLS of the WT, *ale1Δ* (**B**) and *slc1Δ* (**G**) strains. The *p* values displayed on a blue color background indicate that PE21 prolongs the CLS of the *ale1Δ* (**B**) and *slc1Δ* (**G**) strains to a lower extent than that of the WT strain. (**C**, **D**, **H**, **I**) Survival curves shown in (**A**, **F**) were used to calculate the fold of increase of the mean (**C**, **H**) and maximum (**D**, **I**) CLS by PE21 for the WT and *ale1Δ* (**C**, **D**) and WT and *slc1Δ* (**H**, **I**) strains. Data are presented as means ± SEM (*n =*3; ^\*\*^ *p \<*0.01). (**E**, **J**) The maximum concentration of free fatty acids (FFA), which was observed in WT and *ale1Δ* (**E**) or WT and *slc1Δ* (**J**) cells recovered on day 3 of culturing with PE21, is shown. Data are presented as means ± SEM (*n =*4; ^\*^ *p \<*0.05; ^\*\*^ *p \<*0.01).](oncotarget-10-5780-g004){#F4}

![The *tgl1Δ* and *tgl3Δ* mutations eliminate enzymes involved in the formation of FFA as products of TAG lipolysis.\
These mutations decrease cellular FFA concentration and increase the efficiency with which PE21 prolongs yeast CLS. WT cells and mutant cells carrying a single-gene-deletion mutation eliminating either Tgl1 or Tgl3 were cultured in the synthetic minimal YNB medium initially containing 2% glucose with 0.1% PE21 or without it. (**A**, **F**) Survival curves of the chronologically aging WT and *tgl1Δ* (**A**) or WT and *tgl3Δ* (**F**) strains are shown. Data are presented as means ± SEM (*n =*3). Data for the WT strain cultured with or without PE21 are replicated in the graphs of (**A**) and (**F**) and [Figures 3A](#F3){ref-type="fig"}, [3F](#F3){ref-type="fig"}, [4A](#F4){ref-type="fig"}, [4F](#F4){ref-type="fig"}, [6A](#F6){ref-type="fig"}, [6F](#F6){ref-type="fig"}, [10A](#F10){ref-type="fig"}--[10D](#F10){ref-type="fig"}, [11A](#F11){ref-type="fig"}--[11C](#F11){ref-type="fig"}, [14A](#F14){ref-type="fig"}--[14D](#F14){ref-type="fig"}, [15A](#F15){ref-type="fig"}--[15D](#F15){ref-type="fig"}. (**B**, **G**) *p* Values for different pairs of survival curves of the WT and *tgl1Δ* (**B**) or WT and *tgl3Δ* (**G**) strains cultured with or without PE21. Survival curves shown in (**A)** or (**F)** (respectively) were compared. Two survival curves were considered statistically different if the *p* value was less than 0.05. The *p* values for comparing pairs of survival curves using the logrank test were calculated as described in Materials and Methods. The *p* values displayed on a yellow color background indicate that PE21 statistically significantly prolongs the CLS of the WT, *tgl1Δ* (**B**) and *tgl3Δ* (**G**) strains. The *p* values displayed on a blue color background indicate that PE21 prolongs the CLS of the *tgl1Δ* (**B**) and *tgl3Δ* (**G**) strains to a lower extent than that of the WT strain. (**C**, **D**, **H**, **I**) Survival curves shown in (**A**, **F**) were used to calculate the fold of increase of the mean (**C**, **H**) and maximum (**D**, **I**) CLS by PE21 for the WT and *tgl1Δ* (**C**, **D**) and WT and *tgl3Δ* (**H**, **I**) strains. Data are presented as means ± SEM (*n =*3; ^\*^ *p \<*0.05). (**E**, **J**) The maximum concentration of free fatty acids (FFA), which was observed in WT and *tgl1Δ* (**E**) or WT and *tgl3Δ* (**J**) cells recovered on day 3 of culturing with PE21, is shown. Data are presented as means ± SEM (*n =*4; ^\*^ *p \<*0.05; ^\*\*^ *p \<*0.01).](oncotarget-10-5780-g005){#F5}

![The *tgl4Δ* and *tgl5Δ* mutations eliminate enzymes that catalyze the formation of FFA as products of TAG lipolysis.\
These mutations cause a decline in cellular FFA concentration and elicit a rise in the efficiency of yeast CLS extension by PE21. WT cells and mutant cells carrying a single-gene-deletion mutation eliminating either Tgl4 or Tgl5 were cultured in the synthetic minimal YNB medium initially containing 2% glucose with 0.1% PE21 or without it. (**A**, **F**) Survival curves of the chronologically aging WT and *tgl4Δ* (**A**) or WT and *tgl5Δ* (**F**) strains are shown. Data are presented as means ± SEM (*n =*3). Data for the WT strain cultured with or without PE21 are replicated the graphs of (**A**) and (**F**) and [Figures 3A](#F3){ref-type="fig"}, [3F](#F3){ref-type="fig"}, [4A](#F4){ref-type="fig"}, [4F](#F4){ref-type="fig"}, [5A](#F5){ref-type="fig"}, [5F](#F5){ref-type="fig"}, [10A](#F10){ref-type="fig"}--[10D](#F10){ref-type="fig"}, [11A](#F11){ref-type="fig"}--[11C](#F11){ref-type="fig"}, [14A](#F14){ref-type="fig"}--[14D](#F14){ref-type="fig"}, [15A](#F15){ref-type="fig"}--[15D](#F15){ref-type="fig"}. (**B**, **G**) *p* Values for different pairs of survival curves of the WT and *tgl4Δ* (**B**) or WT and *tgl5Δ* (**G**) strains cultured with or without PE21. Survival curves shown in (**A** or **F**) (respectively) were compared. Two survival curves were considered statistically different if the *p* value was less than 0.05. The *p* values for comparing pairs of survival curves using the logrank test were calculated as described in Materials and Methods. The *p* values displayed on a yellow color background indicate that PE21 statistically significantly extends the CLS of the WT, *tgl4Δ* (**B**) and *tgl5Δ* (**G**) strains. The *p* values displayed on a blue color background indicate that PE21 extends the CLS of the *tgl4Δ* (**B**) and *tgl5Δ* (**G**) strains to a lower extent than that of the WT strain. (**C**, **D**, **H**, **I**) Survival curves shown in (**A**, **F**) were used to calculate the fold of increase of the mean (**C**, **H**) and maximum (**D**, **I**) CLS by PE21 for the WT and *tgl4Δ* (**C**, **D**) and WT and *tgl5Δ* (**H**, **I**) strains. Data are presented as means ± SEM (*n =*3; ^\*\*^ *p \<*0.01; ns, not significant). (**E**, **J**) The maximum concentration of free fatty acids (FFA), which was observed in WT and *tgl4Δ* (**E**) or WT and *tgl5Δ* (**J**) cells recovered on day 3 of culturing with PE21, is shown. Data are presented as means ± SEM (*n =*4; ^\*^ *p \<*0.05; ^\*\*^ *p \<*0.01).](oncotarget-10-5780-g006){#F6}

Using the above data on the values of CLS and cellular FFA concentration for WT and mutant strains, we compared the PE21-dependent fold increase of mean or maximum CLS and the highest intracellular concentration of FFA in yeast cells cultured with PE21; FFA concentration was the highest in WT, *faa1Δ*, *faa4Δ*, *ale1Δ*, *slc1Δ*, *tgl1Δ*, *tgl3Δ*, *tgl4Δ* and *tgl5Δ* cells recovered on day 3 of culturing. We revealed that the Pearson's correlation coefficient (*r*) values for the correlation between these two compared variables are less than - 0.9 for both possible pairwise combinations of the mean or maximum CLS and the highest intracellular concentration of FFA ([Supplementary Figure 3](#SD1){ref-type="supplementary-material"}). Because the Pearson's *r* value ranging from -0.9 to -1.0 is considered a very high negative correlation between the two variables \[[@R218]\], we concluded that the PE21-dependent fold increase of mean or maximum CLS has a very high negative correlation with FFA concentration in the yeast cell. This observation confirms that, as predicted by our hypothesis on the first mechanism of PE21-dependent longevity extension, the efficiency of such extension inversely correlates with the intracellular concentration of FFA. Thus, PE21 delays yeast chronological aging and prolongs yeast CLS in part because it decreases FFA concentration in the yeast cell.

Our hypothesis on the first mechanism suggests that, because PE21 maintains FFA concentration below the toxic threshold, it may weaken an age-related form of FFA-driven liponecrotic RCD ([Figure 2](#F2){ref-type="fig"}). To test this suggestion, we first used live-cell fluorescence microscopy with propidium iodide (PI) to examine if PE21 can influence the age-related onset and/or progression of this mode of necrotic RCD in WT and mutant strains. PI positive staining is characteristic of necrotic RCD because PI is a stain used to visualize the loss of PM integrity, a hallmark event of necrotic RCD in yeast \[[@R11], [@R150]--[@R155], [@R219]\]. We found the following: 1) in WT cells, PE21 postpones the onset of necrosis since day 2 of culturing and decelerates the progression of necrotic RCD after that ([Figure 7A](#F7){ref-type="fig"} and [7B](#F7){ref-type="fig"}); 2) since day 3 of culturing with PE21, the *faa1Δ*, *faa4Δ*, *ale1Δ* and *slc1Δ* mutations significantly increase the percentage of cells displaying PI positive staining typical of necrotic RCD ([Supplementary Figure 4A](#SD1){ref-type="supplementary-material"}--[4D](#SD1){ref-type="supplementary-material"} and [4J](#SD1){ref-type="supplementary-material"}); and 3) since day 3 of culturing with PE21, the *tgl1Δ*, *tgl3Δ*, *tgl4Δ* and *tgl5Δ* mutations decrease the percentage of cells exhibiting PI positive staining characteristic of necrotic RCD ([Supplementary Figure 4E](#SD1){ref-type="supplementary-material"}--[4H](#SD1){ref-type="supplementary-material"} and [4J](#SD1){ref-type="supplementary-material"}). Our comparison of the maximum percentage of cells displaying PI positive staining (which was observed in WT, *faa1Δ*, *faa4Δ*, *ale1Δ*, *slc1Δ*, *tgl1Δ*, *tgl3Δ*, *tgl4Δ* and *tgl5Δ* cells recovered on day 4 of culturing with PE21) and the highest intracellular concentration of FFA in these cells has revealed that the Pearson's *r* value for the correlation between these two compared variables is more than 0.9 ([Supplementary Figure 4I](#SD1){ref-type="supplementary-material"}). Hence, the percentage of cells undergoing necrotic RCD has a very high positive correlation \[[@R218]\] and, therefore, directly correlates with FFA concentration in the yeast cell. This finding supports our assumption that PE21 delays the age-related onset of necrotic RCD and slows down the progression of this mode of RCD because it allows to sustain FFA concentration below the toxic threshold.

![PE21 delays an age-related onset of necrotic death in yeast cells, decelerates the progression of the necrotic cell death process, and makes yeast less susceptible to a liponecrotic mode of regulated cell death (RCD).\
WT cells were cultured in the synthetic minimal YNB medium initially containing 2% glucose with 0.1% PE21 or without it. (**A**) Cells recovered on different days of culturing with or without PE21 were visualized using the differential interference contrast (DIC) microscopy and stained with propidium iodide (PI) as described in Materials and Methods. PI positive staining identifies cells that are permeable to PI because their plasma membranes have been damaged. Such loss of plasma membrane integrity is characteristic of necrotic cell death. (**B**) Percentage of cells displaying PI positive staining, a hallmark event of necrotic cell death. Images like the representative images shown in (**A**) were quantitated. Data are presented as means ± SEM (*n =*3; ^\*^ *p \<*0.05; ^\*\*^ *p \<*0.01). Data for the WT strain cultured with PE21 are replicated in [Supplementary Figure 4A](#SD1){ref-type="supplementary-material"}--[4H](#SD1){ref-type="supplementary-material"}. (**C**) Clonogenic survival of cells recovered on different days of culturing with or without PE21 and then exposed for 2 h to 0.1 mM palmitoleic acid (POA) as described in Materials and Methods. POA is a monounsaturated form of FFA that triggers a liponecrotic mode of RCD. Data are presented as means ± SEM (*n =*3; ^\*^ *p \<*0.05; ^\*\*^ *p \<*0.01). Data for the WT strain cultured with PE21 are replicated in [Supplementary Figure 5A](#SD1){ref-type="supplementary-material"}--[5H](#SD1){ref-type="supplementary-material"}.](oncotarget-10-5780-g007){#F7}

We then investigated if PE21 can affect the susceptibilities of WT and mutant strains to liponecrotic RCD. This mode of age-related RCD is known to be initiated in response to a brief exposure of yeast cells to exogenous FFA \[[@R52], [@R150], [@R151], [@R153]\]. The extent of liponecrotic RCD was measured as a decline in clonogenic survival of yeast cells that were treated for 2 h with a monounsaturated form of FFA called palmitoleic acid (POA). We found the following: 1) PE21 decreases the susceptibility of WT cells to liponecrotic RCD since day 2 of culturing ([Figure 7C](#F7){ref-type="fig"}); 2) since day 2 of culturing with PE21, the *faa1Δ*, *faa4Δ*, *ale1Δ* and *slc1Δ* mutations make yeast cells more sensitive to liponecrotic RCD ([Supplementary Figure 5A](#SD1){ref-type="supplementary-material"}--[5D](#SD1){ref-type="supplementary-material"} and [5J](#SD1){ref-type="supplementary-material"}); and 3) since day 3 of culturing with PE21, the *tgl1Δ*, *tgl3Δ*, *tgl4Δ* and *tgl5Δ* mutations make yeast cells more resistant to liponecrotic RCD ([Supplementary Figure 5E](#SD1){ref-type="supplementary-material"}--[5H](#SD1){ref-type="supplementary-material"} and [5J](#SD1){ref-type="supplementary-material"}). Our comparison of the minimum percentage of clonogenic survival of POA-treated cells (which was observed in WT, *faa1Δ*, *faa4Δ*, *ale1Δ*, *slc1Δ*, *tgl1Δ*, *tgl3Δ*, *tgl4Δ* and *tgl5Δ* cells recovered on day 4 of culturing with PE21) and the highest intracellular concentration of FFA in these cells has shown that the Pearson's *r* value for the correlation between these two compared variables is less than - 0.9 ([Supplementary Figure 5I](#SD1){ref-type="supplementary-material"}). We therefore have inferred that the resistance of yeast cells to liponecrotic RCD has a very high negative correlation \[[@R218]\] and, thus, inversely correlates with the intracellular concentration of FFA in the yeast cell. This observation indicates that PE21 makes yeast cells less vulnerable to liponecrotic RCD by allowing to lower FFA concentration.

Altogether, the above findings validate our hypothesis on the first mechanism through which PE21 decelerates yeast chronological aging and prolongs yeast CLS ([Figure 2](#F2){ref-type="fig"}). In this mechanism, PE21 decreases the risk of aging-associated liponecrotic RCD and increases the chance of elderly cells to survive because PE21 enables yeast cells to maintain FFA concentration below the toxic threshold.

PE21 causes global remodeling of the cellular proteome in an age-related manner {#s2_6}
-------------------------------------------------------------------------------

To make a first step towards testing our hypothesis on the second and third mechanisms of yeast longevity extension by PE21, we wanted to get a broader view of cellular processes that are affected by PE21 in yeast. We therefore used quantitative mass spectrometry to compare the cellular proteomes of WT yeast cultured in the presence of PE21 or in its absence.

We found that PE21 causes changes in the relative concentrations of many cellular proteins in WT yeast ([Figure 8A](#F8){ref-type="fig"}--[8D](#F8){ref-type="fig"}). We also noticed that the total number of proteins upregulated or downregulated in WT cells in response to PE21 exposure is increased with the chronological age of these cells ([Figure 8E](#F8){ref-type="fig"}).

![PE21 causes changes in the relative concentrations of many cellular proteins in an age-related manner.\
WT cells were cultured in the synthetic minimal YNB medium initially containing 2% glucose with 0.1% PE21 or without it. Cells were recovered on days 1, 2, 3 and 4 of culturing. Mass spectrometry-based identification and quantitation of proteins recovered from these cells, and the calculation of the relative abundance of cellular proteins in a pair of analyzed datasets (i. e. in the datasets of age-matched WT cells cultured with or without PE21), were performed as described in Materials and Methods. (**A**--**D**) Scatter plots comparing the relative abundance of cellular proteins between specified datasets were plotted on a log-log scale spanning six orders of magnitude. (**E**) The total number of proteins that are upregulated (displayed in red) or downregulated (displayed in blue) in response to the treatment with PE21. Data are presented as means ± SEM (*n =*2).](oncotarget-10-5780-g008){#F8}

We used principal component analysis (PCA) to compare the proteome of WT cells cultured in the presence of PE21 to the proteome of age-matched WT cells cultured in the absence of PE21; the cells were recovered on days 1, 2, 3 or 4 of culturing. Our PCA revealed that PE21 elicits a distinct cellular proteome profile in WT yeast that significantly differs from a profile of the cellular proteome in WT yeast cultured in the absence of PE21 ([Supplementary Figure 6A](#SD1){ref-type="supplementary-material"}--[6D](#SD1){ref-type="supplementary-material"}). This distinct PE21-driven cellular proteome profile was observed in WT cells recovered on any of the four days of culturing ([Supplementary Figure 6A](#SD1){ref-type="supplementary-material"}--[6D](#SD1){ref-type="supplementary-material"}). The sample with PE21 and the reference without PE21 were separated farthest from each other (i. e. 30 and 55 units of distance between final cluster centers along the PC1 and PC2 axes, respectively) in case of the cellular proteomes of chronologically old WT cells recovered on day 4 of culturing ([Supplementary Figure 6D](#SD1){ref-type="supplementary-material"}). Although the sample with PE21 and the reference without PE21 were also separated from each other in case of the cellular proteomes of chronologically young WT cells recovered on day 1 of culturing, they were clustered much closer to each other (i. e. 12 and 4 units of distance between final cluster centers along the PC1 and PC2 axes, respectively) than those of chronologically old WT cells recovered on day 4 (compare [Supplementary Figure 6A](#SD1){ref-type="supplementary-material"} and [6D](#SD1){ref-type="supplementary-material"}).

In sum, these findings indicate that PE21 prompts the establishment of a distinct cellular proteome profile in WT yeast and that the efficiency with which PE21 changes this profile is gradually increased with the chronological age of WT yeast.

PE21 prolongs longevity of chronologically aging yeast in part because it promotes UPR^ER^ {#s2_7}
------------------------------------------------------------------------------------------

Our hypothesis on the second mechanism through which PE21 may extend longevity of chronologically aging yeast assumes that, because PE21 alters the ER lipidome, it stimulates the UPR^ER^ system ([Figure 2](#F2){ref-type="fig"}); such PE21-driven stimulation of UPR^ER^ may be responsible, in part, for the observed abilities of PE21 to slow down an age-related decline in protein, lipid and nucleic acid homeostasis and to decelerate an aging-associated weakening of cell resistance to oxidative and thermal stresses \[[@R55]\]. In support of this assumption, we found that in WT yeast PE21 alters the relative concentrations of various cellular proteins whose upregulation or downregulation is indispensable for the restoration and maintenance of cellular homeostasis because it is essential for a proper control of the UPR^ER^ system.

We noticed that PE21 increases the abundance of many cellular proteins known to be upregulated during the UPR^ER^ response in yeast \[[@R159], [@R161], [@R164], [@R181], [@R188], [@R189], [@R193], [@R202], [@R220]\]. The cellular proteins upregulated by PE21 included the following ones: 1) chaperones involved in protein folding and assembly in the ER or the cytosol ([Figure 9A](#F9){ref-type="fig"}); 2) proteins that catalyze *N*-linked protein glycosylation or *O*-linked protein mannosylation in the ER ([Figure 9B](#F9){ref-type="fig"}); 3) stress response proteins that prevent and/or repair an oxidative or thermal damage to proteins and/or lipids in the ER, mitochondria, cytosol and/or PM ([Figure 9C](#F9){ref-type="fig"}); 4) protein components of the ubiquitin-proteasome system involved in the degradation of improperly folded proteins that are accumulated in the ER and then exported to the cytosol ([Figure 9D](#F9){ref-type="fig"}); 5) proteins implicated in vesicular traffic from the ER throughout the secretory pathway ([Figure 9E](#F9){ref-type="fig"}); and 6) proteins that catalyze lipid synthesis in the ER and mitochondria ([Figure 9F](#F9){ref-type="fig"}). Of note, the PE21-dependent increase in the abundance of enzymes catalyzing the synthesis of PA (i. e. Faa1, Faa4, Fat1, Slc1 and Slc4), PS (i. e. Cho1), PE (i. e. Psd1), PC (i. e. Cho2 and Opi3) and PI (i. e. Pis1) in the ER and mitochondria ([Figure 9F](#F9){ref-type="fig"} and [Supplementary Figure 1](#SD1){ref-type="supplementary-material"}) can satisfactorily explain the PE21-dependent rise in the concentrations of these glycerophospholipids ([Figure 1C](#F1){ref-type="fig"}--[1G](#F1){ref-type="fig"}). It needs to be emphasized that, as we found, a single-gene-deletion mutation eliminating Faa1, Faa4 or Slc1 causes a significant decline in longevity-extending efficiency of PE21 ([Figures 3A](#F3){ref-type="fig"}--[3D](#F3){ref-type="fig"}, [3F](#F3){ref-type="fig"}--[3I](#F3){ref-type="fig"} and [4F](#F4){ref-type="fig"}--[4I](#F4){ref-type="fig"}). Thus, PE21 extends longevity of chronologically aging yeast in part because it stimulates a branch of the UPR^ER^ network responsible for glycerophospholipid synthesis in the ER. As discussed below in this section, the PE21-driven upregulation of other UPR^ER^ network branches also contributes to the PE21-dependent extension of yeast CLS.

![PE21 increases the abundance of six classes of cellular proteins known to be upregulated during the UPR^ER^ response in yeast.\
WT cells were cultured in the synthetic minimal YNB medium initially containing 2% glucose with 0.1% PE21 or without it. Cells were recovered on days 1, 2, 3 and 4 of culturing. Mass spectrometry-based identification and quantitation of proteins recovered from these cells, and the calculation of the relative abundance of cellular proteins in a pair of analyzed datasets (i. e. in the datasets of age-matched WT cells cultured with or without PE21), were performed as described in Materials and Methods. (**A**--**F**) Relative levels of proteins in WT cells cultured with PE21 (fold difference relative to those in WT cells cultured without PE21) are shown. These proteins include the following ones: chaperones involved in protein folding and assembly in the endoplasmic reticulum or the cytosol (**A**), proteins that catalyze *N*-linked protein glycosylation or *O*-linked protein mannosylation in the endoplasmic reticulum (**B**), stress response proteins that prevent and/or repair an oxidative or thermal damage to proteins in the endoplasmic reticulum, cytosol and plasma membrane (**C**), proteins involved in the degradation of improperly folded proteins accumulated in the endoplasmic reticulum via the ubiquitin-proteasome pathway (**D**), proteins implicated in vesicular traffic from the endoplasmic reticulum throughout the secretory pathway (**E**), and proteins that catalyze the synthesis of lipids in the endoplasmic reticulum and mitochondria (**F**). The 2-fold increase in the ratio "protein abundance with PE21/protein abundance without PE21" is shown by a dotted line. Data are presented as mean values of 2 independent experiments. Abbreviation: emPAI, the exponentially modified protein abundance index, a measure of the relative abundance of cellular proteins in a pair of analyzed datasets.](oncotarget-10-5780-g009){#F9}

We also found that PE21 decreases the abundance of cellular proteins known to be downregulated during the UPR^ER^ response in yeast \[[@R159], [@R161], [@R164], [@R181], [@R188], [@R189], [@R193], [@R202], [@R220]\]. These proteins have been implicated in ribosome assembly, tRNA synthesis and protein translation in the cytosol ([Supplementary Figure 7](#SD1){ref-type="supplementary-material"}).

We thought that cellular proteins upregulated by both PE21 and UPR^ER^ stimuli may play essential roles in enabling aging delay by PE21. We therefore hypothesized that single-gene-deletion mutations eliminating such proteins may decrease the aging-delaying (geroprotective) efficiency of PE21. In support of our hypothesis, yeast mutants that lack the following proteins upregulated in a PE21- and UPR^ER^-dependent manner exhibited a statistically significant decline in the geroprotective efficiency of PE21: 1) Emc2, Erj5, Erv2 and Eug1, all of which are chaperones assisting in the folding and assembly of other proteins within the ER ([Figure 10A](#F10){ref-type="fig"}, [10E](#F10){ref-type="fig"}, [10I](#F10){ref-type="fig"} and [10J](#F10){ref-type="fig"} for the *emc2Δ* mutant; [Supplementary Figure 8A](#SD1){ref-type="supplementary-material"} and [8B](#SD1){ref-type="supplementary-material"} for the *erj5Δ*, *erv2Δ* and *eug1Δ* mutants); 2) Alg3, Alg12, Ost3 and Ost6, all of which are enzymes catalyzing *N*-linked protein glycosylation within the ER ([Figure 10B](#F10){ref-type="fig"}, [10F](#F10){ref-type="fig"}, [10I](#F10){ref-type="fig"} and [10J](#F10){ref-type="fig"} for the *alg3Δ* mutant; [Supplementary Figure 8C](#SD1){ref-type="supplementary-material"} and [8D](#SD1){ref-type="supplementary-material"} for the *alg12Δ*, *ost3Δ* and *ost6Δ* mutants); 3) Ctt1, Gpx2, Grx1 and Grx2, all of which are stress response proteins preventing and/or repairing an oxidative damage to proteins and/or lipids in the cytosol and mitochondria ([Figure 10C](#F10){ref-type="fig"}, [10G](#F10){ref-type="fig"}, [10I](#F10){ref-type="fig"} and [10J](#F10){ref-type="fig"} for the *ctt1Δ* mutant; [Supplementary Figure 8E](#SD1){ref-type="supplementary-material"} and [8F](#SD1){ref-type="supplementary-material"} for the *gpx2Δ*, *grx1Δ* and *grx2Δ* mutants); 4) Fes1, Rpn4, Ssa1 and Ubc8, all of which are components of the ubiquitin-proteasome pathway for the degradation of improperly folded proteins that amass in the ER ([Figure 10D](#F10){ref-type="fig"}, [10H](#F10){ref-type="fig"}, [10I](#F10){ref-type="fig"} and [10J](#F10){ref-type="fig"} for the *fes1Δ* mutant; [Supplementary Figure 8G](#SD1){ref-type="supplementary-material"} and [8H](#SD1){ref-type="supplementary-material"} for the *rpn4Δ*, *ssa1Δ* and *ubc8Δ* mutants); 5) Bst1, Erp1, Erp2 and Erv29, all of which are proteins involved in vesicular traffic from the ER to the Golgi apparatus ([Figure 11A](#F11){ref-type="fig"}, [11D](#F11){ref-type="fig"}, [11G](#F11){ref-type="fig"} and [11H](#F11){ref-type="fig"} for the *bst1Δ* mutant; [Supplementary Figure 8I](#SD1){ref-type="supplementary-material"} and [8J](#SD1){ref-type="supplementary-material"} for the *erp1Δ*, *erp2Δ* and *erv29Δ* mutants); and 6) Fat1 and Opi3, both being implicated in glycerophospholipid synthesis within the ER ([Figure 11B](#F11){ref-type="fig"}, [11E](#F11){ref-type="fig"}, [11G](#F11){ref-type="fig"} and [11H](#F11){ref-type="fig"} for the *fat1Δ* mutant; [Supplementary Figure 8K](#SD1){ref-type="supplementary-material"} and [8L](#SD1){ref-type="supplementary-material"} for the *opi3Δ* mutant; as indicated above and as shown in [Figure 3A](#F3){ref-type="fig"}--[3D](#F3){ref-type="fig"}, [3F](#F3){ref-type="fig"}--[3I](#F3){ref-type="fig"} and [4F](#F4){ref-type="fig"}--[4I](#F4){ref-type="fig"}, the geroprotective efficiency of PE21 is also decreased in yeast mutants lacking other glycerophospholipid synthesis enzymes that are upregulated in a PE21- and UPR^ER^-dependent manner).

![Single-gene-deletion mutations eliminating proteins that are upregulated by both PE21 and UPR^ER^ stimuli decrease the efficiency with which PE21 extends yeast longevity.\
WT cells and mutant cells carrying a single-gene-deletion mutation eliminating either Emc2, Alg3, Ctt1 or Fes1 were cultured in the synthetic minimal YNB medium initially containing 2% glucose with 0.1% PE21 or without it. (**A**--**D**) Survival curves of the chronologically aging WT and *emc2Δ* (**A**), WT and *alg3Δ* (**B**), WT and *ctt1Δ* (**C**) or WT and *fes1Δ* (**D**) strains are shown. Data are presented as means ± SEM (*n =*3). Data for the WT strain cultured with or without PE21 are replicated in the graphs of (**A**) and (**F**) and [Figures 3A](#F3){ref-type="fig"}, [3F](#F3){ref-type="fig"}, [4A](#F4){ref-type="fig"}, [4F](#F4){ref-type="fig"}, [5A](#F5){ref-type="fig"}, [5F](#F5){ref-type="fig"}, [6A](#F6){ref-type="fig"}, [6F](#F6){ref-type="fig"}, [11A](#F11){ref-type="fig"}--[11C](#F11){ref-type="fig"}, [14A](#F14){ref-type="fig"}--[14D](#F14){ref-type="fig"}, [15A](#F15){ref-type="fig"}--[15D](#F15){ref-type="fig"}. (**E**--**H**) *p* Values for different pairs of survival curves of the WT and *emc2Δ* (**E**), WT and *alg3Δ* (**F**), WT and *ctt1Δ* (**G**) or WT and *fes1Δ* (**H**) strains cultured with or without PE21. Survival curves shown in (**A**--**D**) (respectively) were compared. Two survival curves were considered statistically different if the *p* value was less than 0.05. The *p* values for comparing pairs of survival curves using the logrank test were calculated as described in Materials and Methods. The *p* values displayed on a yellow color background indicate that PE21 statistically significantly prolongs the CLS of the WT (**E**--**H**), *emc2Δ* (**E**), *alg3Δ* (**F**), *ctt1Δ* (**G**) and *fes1Δ* (**H**) strains. The *p* values displayed on a blue color background indicate that PE21 prolongs the CLS of the *emc2Δ* (**E**), *alg3Δ* (**F**), *ctt1Δ* (**G**) and *fes1Δ* (**H**) strains to a lower extent than that of the WT strain. (**I**, **J**) Survival curves shown in (**A**--**D**) were used to calculate the fold of increase of the mean (**I**) and maximum (**J**) CLS by PE21 for the WT, *emc2Δ*, *alg3Δ*, *ctt1Δ* and *fes1Δ* strains. Data are presented as means ± SEM (*n =*3; ^\*^ *p \<*0.05; ^\*\*^ *p \<*0.01).](oncotarget-10-5780-g010){#F10}

![Single-gene-deletion mutations eliminating proteins that are upregulated by both PE21 and UPR^ER^ stimuli decrease the efficiency with which PE21 extends yeast longevity, while a single-gene-deletion mutation eliminating a protein that is downregulated by both PE21 and UPR^ER^ stimuli increases such efficiency.\
WT cells and mutant cells carrying a single-gene-deletion mutation eliminating either Bst1, Fat1 or Abp140 were cultured in the synthetic minimal YNB medium initially containing 2% glucose with 0.1% PE21 or without it. (**A**--**C**) Survival curves of the chronologically aging WT and *bst1Δ* (**A**), WT and *fat1Δ* (**B**) or WT and *abp140Δ* (**C**) strains are shown. Data are presented as means ± SEM (*n =*3). Data for the WT strain cultured with or without PE21 are replicated in the graphs of (**A**) and (**F**) and [Figures 3A](#F3){ref-type="fig"}, [3F](#F3){ref-type="fig"}, [4A](#F4){ref-type="fig"}, [4F](#F4){ref-type="fig"}, [5A](#F5){ref-type="fig"}, [5F](#F5){ref-type="fig"}, [6A](#F6){ref-type="fig"}, [6F](#F6){ref-type="fig"}, [10A](#F10){ref-type="fig"}--[10D](#F10){ref-type="fig"}, [14A](#F14){ref-type="fig"}--[14D](#F14){ref-type="fig"}, [15A](#F15){ref-type="fig"}--[15D](#F15){ref-type="fig"}. (**D**--**F**) *p* Values for different pairs of survival curves of the WT and *bst1Δ* (**D**), WT and *fat1Δ* (**E**) or WT and *abp140Δ* (**F**) strains cultured with or without PE21. Survival curves shown in **A**--**C** (respectively) were compared. Two survival curves were considered statistically different if the *p* value was less than 0.05. The *p* values for comparing pairs of survival curves using the logrank test were calculated as described in Materials and Methods. The *p* values displayed on a yellow color background indicate that PE21 statistically significantly prolongs the CLS of the WT (**D**--**F**), *bst1Δ* (**D**), *fat1Δ* (**E**) and *abp140Δ* (**F**) strains. The *p* values displayed on a blue color background indicate the following: 1) PE21 prolongs the CLS of the *bst11Δ* (**D**) and *fat1Δ* (**E**) strains to a lower extent than that of the WT strain; and 2) PE21 prolongs the CLS of the *fat1Δ* strain (**F**) to a higher extent than that of the WT strain. (**G**, **H**) Survival curves shown in (**A**--**C**) were used to calculate the fold of increase of the mean (**G**) and maximum (**H**) CLS by PE21 for the WT, *bst1Δ*, *fat1Δ* and *abp140Δ* strains. Data are presented as means ± SEM (*n =*3; ^\*^ *p \<*0.05; ^\*\*^ *p \<*0.01).](oncotarget-10-5780-g011){#F11}

We also thought that cellular proteins downregulated by both PE21 and UPR^ER^ stimuli may be important for impeding aging delay by PE21. Our hypothesis was therefore that single-gene-deletion mutations eliminating such proteins may increase the geroprotective efficiency of PE21. In support of our hypothesis, yeast mutants that lack Abp140, Acl4, Caf20 and Gis2 displayed a statistically significant rise in the geroprotective efficiency of PE21 ([Figure 11C](#F11){ref-type="fig"}, [11F](#F11){ref-type="fig"}, [11G](#F11){ref-type="fig"} and [11H](#F11){ref-type="fig"} for the *abp140Δ* mutant; [Supplementary Figure 8M](#SD1){ref-type="supplementary-material"} and [8N](#SD1){ref-type="supplementary-material"} for the *acl4Δ*, *caf20Δ* and *gis2Δ* mutants). These proteins play essential roles in ribosome assembly, tRNA synthesis and protein translation in the cytosol \[[@R221]--[@R228]\] and are downregulated by both PE21 ([Supplementary Figure 7](#SD1){ref-type="supplementary-material"}) and UPR^ER^ stimuli \[[@R159], [@R161], [@R164], [@R181], [@R188], [@R189], [@R193], [@R202], [@R220]\].

Taken together, the above findings validate our hypothesis on the second mechanism by which PE21 delays yeast chronological aging and extends yeast CLS ([Figure 2](#F2){ref-type="fig"}). In this mechanism, PE21 stimulates the UPR^ER^ system, thus slowing an age-related decline in protein and lipid homeostasis and decelerating an aging-associated deterioration of cell resistance to oxidative and thermal stresses.

PE21 extends longevity of chronologically aging yeast in part because it rearranges processes within mitochondria, thus changing functionality of these organelles {#s2_8}
------------------------------------------------------------------------------------------------------------------------------------------------------------------

Our hypothesis on the third mechanism through which PE21 may extend longevity of chronologically aging yeast posits that, because PE21 alters the membrane lipidome of mitochondria, it may reorganize processes within these organelles to change mitochondrial functionality ([Figure 2](#F2){ref-type="fig"}). In our hypothesis, such PE21-dependent change in mitochondrial functionality may be responsible, in part, for the observed ability of PE21 to amend the temporal dynamics of age-related alterations in mitochondrial respiration, mitochondrial membrane potential and mitochondrial ROS production \[[@R55]\]. In support of our hypothesis, we found that in WT yeast PE21 elicits changes the relative concentrations of various mitochondrial proteins implicated in key aspects of mitochondrial functionality.

We noted that PE21 increases the abundance of proteins involved in the following mitochondrial processes: 1) the electron transport chain (ETC) and oxidative phosphorylation (OXPHOS) system in mitochondria ([Figure 12A](#F12){ref-type="fig"} and [12B](#F12){ref-type="fig"}); 2) the mitochondrial tricarboxylic acid (TCA) cycle, glyoxylate cycle, synthesis of NADPH and formation of glutamate (which is a common precursor for the synthesis of other amino acids, folates and glutathione in mitochondria and the cytosol \[[@R229]\]) ([Figure 12C](#F12){ref-type="fig"} and [12D](#F12){ref-type="fig"}); 3) ROS detoxification and oxidative stress protection ([Figure 13A](#F13){ref-type="fig"}); 4) the synthesis of heme and its attachment to proteins ([Figure 13B](#F13){ref-type="fig"}); 5) protein folding and refolding ([Figure 13C](#F13){ref-type="fig"}); and 6) protein import into mitochondria ([Figure 13D](#F13){ref-type="fig"}).

![PE21 increases the abundance of proteins involved in the mitochondrial electron transport chain (ETC), oxidative phosphorylation (OXPHOS) system, tricarboxylic acid (TCA) cycle (TCA), glyoxylate cycle, NADPH synthesis and glutamate formation.\
WT cells were cultured in the synthetic minimal YNB medium initially containing 2% glucose with 0.1% PE21 or without it. Cells were recovered on days 1, 2, 3 and 4 of culturing. Mass spectrometry-based identification and quantitation of proteins recovered from these cells, and the calculation of the relative abundance of cellular proteins in a pair of analyzed datasets (i. e. in the datasets of age-matched WT cells cultured with or without PE21), were performed as described in Materials and Methods. (**A**, **C**) Relative levels of proteins in WT cells cultured with PE21 (fold difference relative to those in WT cells cultured without PE21) are shown. The 2-fold increase in the ratio "protein abundance with PE21/protein abundance without PE21" is shown by a dotted line. Data are presented as mean values of 2 independent experiments. (**B**) Protein components of the mitochondrial ETC and OXPHOS system whose concentrations are increased in yeast cells cultured in the presence of PE21 are displayed in red color. The names of these protein components are provided. Red arrows denote the reactions of electron transport, proton transfer across the inner mitochondrial membrane (IMM) and ATP synthesis that are accelerated due to a PE21-dependent upregulation of protein components of the mitochondrial ETC and OXPHOS system. (**D**) Red arrows indicate the reactions of the TCA cycle, glyoxylate cycle, NADPH synthesis and glutamate formation that are accelerated because of a PE21-dependent upregulation of protein components involved in these metabolic processes within mitochondria. The names of these protein components are provided. Other abbreviations: C, cytochrome *c*; emPAI, the exponentially modified protein abundance index, a measure of the relative abundance of cellular proteins in a pair of analyzed datasets; OMM, outer mitochondrial membrane; Q, ubiquinone (coenzyme Q); III and IV, respiratory complexes III and IV of the mitochondrial ETC.](oncotarget-10-5780-g012){#F12}

![PE21 increases the abundance of mitochondrial proteins implicated in ROS detoxification, heme synthesis and protein attachment, protein folding and refolding, and protein import into mitochondria.\
WT cells were cultured in the synthetic minimal YNB medium initially containing 2% glucose with 0.1% PE21 or without it. Cells were recovered on days 1, 2, 3 and 4 of culturing. Mass spectrometry-based identification and quantitation of proteins recovered from these cells, and the calculation of the relative abundance of cellular proteins in a pair of analyzed datasets (i. e. in the datasets of age-matched WT cells cultured with or without PE21), were performed as described in Materials and Methods. Relative levels of proteins in WT cells cultured with PE21 (fold difference relative to those in WT cells cultured without PE21) are shown. These proteins include the following ones: mitochondrial proteins involved in ROS detoxification and oxidative stress protection (**A**), enzymes catalyzing heme synthesis and proteins facilitating heme attachment to other proteins (**B**), chaperones assisting in the folding and refolding of other mitochondrial proteins (**C**), components of the mitochondrial protein import machinery (**D**). The 2-fold increase in the ratio "protein abundance with PE21/protein abundance without PE21" is shown by a dotted line. Data are presented as mean values of 2 independent experiments. Abbreviation: emPAI, the exponentially modified protein abundance index, a measure of the relative abundance of cellular proteins in a pair of analyzed datasets.](oncotarget-10-5780-g013){#F13}

We also noted that PE21 decreases the abundance of mitochondrial proteins implicated in the division (fission) of mitochondria as well as in RNA synthesis, processing and translation within these organelles ([Supplementary Figure 9](#SD1){ref-type="supplementary-material"}).

It is conceivable that those mitochondrial proteins that are upregulated by PE21 may be essential contributors to a PE21-dependent delay of yeast chronological aging. If this assumption is correct, then single-gene-deletion mutations that eliminate such mitochondrial proteins may reduce the geroprotective potential of PE21. We found that this assumption holds true, as PE21 is a significantly less efficient geroprotective agent for single-gene-deletion mutants that lack the following PE21-inducible mitochondrial proteins: 1) components of the ETC and OXPHOS system in mitochondria ([Figure 14A](#F14){ref-type="fig"}, [14E](#F14){ref-type="fig"}, [14I](#F14){ref-type="fig"} and [14J](#F14){ref-type="fig"} for the *nde1Δ* mutant; [Supplementary Figure 10A](#SD1){ref-type="supplementary-material"} and [10B](#SD1){ref-type="supplementary-material"} for the *ndi1Δ*, *sdh1Δ* and *sdh2Δ* mutants); 2) enzymes of the TCA and glyoxylate cycles in mitochondria ([Figure 14B](#F14){ref-type="fig"}, [14F](#F14){ref-type="fig"}, [14I](#F14){ref-type="fig"} and [14J](#F14){ref-type="fig"} for the *cit1Δ* mutant; [Supplementary Figure 10C](#SD1){ref-type="supplementary-material"} and [10D](#SD1){ref-type="supplementary-material"} for the *cit3Δ*, *idh1Δ* and *idh2Δ* mutants); 3) enzymes implicated in ROS detoxification and oxidative stress protection in mitochondria ([Figure 14C](#F14){ref-type="fig"}, [14G](#F14){ref-type="fig"}, [14I](#F14){ref-type="fig"} and [14J](#F14){ref-type="fig"} for the *ccp1Δ* mutant; [Supplementary Figure 10E](#SD1){ref-type="supplementary-material"} and [10F](#SD1){ref-type="supplementary-material"} for the *glr1Δ*, *gpx1Δ* and *gtt2Δ* mutants); 4) proteins involved in the formation of heme and its attachment to other proteins in mitochondria ([Figure 14D](#F14){ref-type="fig"}, [14H](#F14){ref-type="fig"}, [14I](#F14){ref-type="fig"} and [14J](#F14){ref-type="fig"} for the *cox10Δ* mutant; [Supplementary Figure 10G](#SD1){ref-type="supplementary-material"} and [10H](#SD1){ref-type="supplementary-material"} for the *cox15Δ*, *cyc2Δ* and *cyc3Δ* mutants); 5) chaperones assisting in the folding and refolding of proteins within mitochondria ([Figure 15A](#F15){ref-type="fig"}, [15E](#F15){ref-type="fig"}, [15I](#F15){ref-type="fig"} and [15J](#F15){ref-type="fig"} for the *bcs1Δ* mutant; [Supplementary Figure 10I](#SD1){ref-type="supplementary-material"} and [10J](#SD1){ref-type="supplementary-material"} for the *ecm10Δ*, *hsp78Δ* and *mdj1Δ* mutants); and 6) components of the mitochondrial protein import machinery ([Figure 15B](#F15){ref-type="fig"}, [15F](#F15){ref-type="fig"}, [15I](#F15){ref-type="fig"} and [15J](#F15){ref-type="fig"} for the *hot13Δ* mutant; [Supplementary Figure 10K](#SD1){ref-type="supplementary-material"} and [10L](#SD1){ref-type="supplementary-material"} for the *mdj2Δ*, *mgr2Δ* and *mic60Δ* mutants).

![Single-gene-deletion mutations eliminating mitochondrial proteins that are upregulated by PE21 reduce the geroprotective potential of PE21.\
WT cells and mutant cells carrying a single-gene-deletion mutation eliminating either Nde1, Cit1, Ccp1 or Cox10 were cultured in the synthetic minimal YNB medium initially containing 2% glucose with 0.1% PE21 or without it. (**A**--**D**) Survival curves of the chronologically aging WT and *nde1Δ* (**A**), WT and *cit1Δ* (**B**), WT and *ccp1Δ* (**C**) or WT and *cox10Δ* (**D**) strains are shown. Data are presented as means ± SEM (*n =*3). Data for the WT strain cultured with or without PE21 replicated in the graphs of (**A**) and (**F**) And [Figures 3A](#F3){ref-type="fig"}, [3F](#F3){ref-type="fig"}, [4A](#F4){ref-type="fig"}, [4F](#F4){ref-type="fig"}, [5A](#F5){ref-type="fig"}, [5F](#F5){ref-type="fig"}, [6A](#F6){ref-type="fig"}, [6F](#F6){ref-type="fig"}, [10A](#F10){ref-type="fig"}--[10D](#F10){ref-type="fig"}, [11A](#F11){ref-type="fig"}--[11C](#F11){ref-type="fig"}, [15A](#F15){ref-type="fig"}--[15D](#F15){ref-type="fig"}. (**E**--**H**) *p* Values for different pairs of survival curves of the WT and *nde1Δ* (**E**), WT and *cit1Δ* (**F**), WT and *ccp1Δ* (**G**) or WT and *cox10Δ* (**H**) strains cultured with or without PE21. Survival curves shown in **A**--**D** (respectively) were compared. Two survival curves were considered statistically different if the *p* value was less than 0.05. The *p* values for comparing pairs of survival curves using the logrank test were calculated as described in Materials and Methods. The *p* values displayed on a yellow color background indicate that PE21 statistically significantly prolongs the CLS of the WT (**E--H**), *nde1Δ* (**E**), *cit1Δ* (**F**), *ccp1Δ* (**G**) and *cox10Δ* (**H**) strains. The *p* values displayed on a blue color background indicate that PE21 prolongs the CLS of the *nde1Δ* (**E**), *cit1Δ* (**F**), *ccp1Δ* (**G**) and *cox10Δ* (**H**) strains to a lower extent than that of the WT strain. (**I**, **J**) Survival curves shown in (**A**--**D**) were used to calculate the fold of increase of the mean (**I**) and maximum (**J**) CLS by PE21 for the WT, *nde1Δ*, *cit1Δ*, *ccp1Δ* and *cox10Δ* strains. Data are presented as means ± SEM (*n =*3; ^\*^ *p \<*0.05; ^\*\*^ *p \<*0.01).](oncotarget-10-5780-g014){#F14}

![Single-gene-deletion mutations eliminating mitochondrial proteins that are upregulated by PE21 decrease the geroprotective potential of PE21, whereas single-gene-deletion mutations eliminating mitochondrial proteins that are downregulated by PE21 increases such potential.\
WT cells and mutant cells carrying a single-gene-deletion mutation eliminating either Bcs1, Hot13, Dnm1 or Ifm1 were cultured in the synthetic minimal YNB medium initially containing 2% glucose with 0.1% PE21 or without it. (**A**--**D**) Survival curves of the chronologically aging WT and *bcs1Δ* (**A**), WT and *hot13Δ* (**B**), WT and *dnm1Δ* (**C**) or WT and *ifm1Δ* (**D**) strains are shown. Data are presented as means ± SEM (*n =*3). Data for the WT strain cultured with or without PE21 are replicated in the graphs of (**A**) and (**F**) and [Figures 3A](#F3){ref-type="fig"}, [3F](#F3){ref-type="fig"}, [4A](#F4){ref-type="fig"}, [4F](#F4){ref-type="fig"}, [5A](#F5){ref-type="fig"}, [5F](#F5){ref-type="fig"}, [6A](#F6){ref-type="fig"}, [6F](#F6){ref-type="fig"}, [10A](#F10){ref-type="fig"}--[10D](#F10){ref-type="fig"}, [11A](#F11){ref-type="fig"}--[11C](#F11){ref-type="fig"}, [14A](#F14){ref-type="fig"}--[14D](#F14){ref-type="fig"}. (**E**--**H**) *p* Values for different pairs of survival curves of the WT and *bcs1Δ* (**E**), WT and *hot13Δ* (**F**), WT and *dnm1Δ* (**G**) or WT and *ifm1Δ* (**H**) strains cultured with or without PE21. Survival curves shown in **A**--**D** (respectively) were compared. Two survival curves were considered statistically different if the *p* value was less than 0.05. The *p* values for comparing pairs of survival curves using the logrank test were calculated as described in Materials and Methods. The *p* values displayed on a yellow color background indicate that PE21 statistically significantly prolongs the CLS of the WT (**E**--**H**), *bcs1Δ* (**E**), *hot13Δ* (**F**), *dnm1Δ* (**G**) and *ifm1Δ* (**H**) strains. The *p* values displayed on a blue color background indicate that PE21 prolongs the CLS of the *bcs1Δ* (**E**), *hot13Δ* (**F**), *dnm1Δ* (**G**) and *ifm1Δ* (**H**) strains to a lower extent than that of the WT strain. (**I**, **J**) Survival curves shown in (**A**--**D**) were used to calculate the fold of increase of the mean (**I**) and maximum (**J**) CLS by PE21 for the WT, *bcs1Δ*, *hot13Δ*, *dnm1Δ* and *ifm1Δ* strains. Data are presented as means ± SEM (*n =*3; ^\*^ *p \<*0.05; ^\*\*^ *p \<*0.01).](oncotarget-10-5780-g015){#F15}

It is also plausible that those mitochondrial proteins that are downregulated by PE21 may have important contributions to the suppression of a geroprotective action of PE21. One could therefore assume that single-gene-deletion mutations that eliminate such mitochondrial proteins may enhance the geroprotective potential of PE21. This assumption holds true, as we observed that PE21 is a significantly more efficient geroprotector for single-gene-deletion mutants that lack the following PE21-suppresible mitochondrial proteins: 1) components of the mitochondrial division (fission) machinery ([Figure 15C](#F15){ref-type="fig"}, [15G](#F15){ref-type="fig"}, [15I](#F15){ref-type="fig"} and [15J](#F15){ref-type="fig"} for the *dnm1Δ* mutant; [Supplementary Figure 10M](#SD1){ref-type="supplementary-material"} and [10N](#SD1){ref-type="supplementary-material"} for the *fis1Δ*, *mdm36Δ* and *mdv1Δ* mutants); and 2) proteins involved in RNA synthesis, processing and translation within mitochondria ([Figure 15D](#F15){ref-type="fig"}, [15H](#F15){ref-type="fig"}, [15I](#F15){ref-type="fig"} and [15J](#F15){ref-type="fig"} for the *ifm1Δ* mutant; [Supplementary Figure 10O](#SD1){ref-type="supplementary-material"} and [10P](#SD1){ref-type="supplementary-material"} for the *img1Δ*, *img2Δ* and *mef1Δ* mutants).

In sum, the above findings confirm our hypothesis on the third mechanism through which PE21 decelerates yeast chronological aging and prolongs yeast longevity ([Figure 2](#F2){ref-type="fig"}). This mechanism consists in a PE21-driven remodeling of certain processes taking place within mitochondria and the resulting changes in functionality of these organelles.

DISCUSSION {#s3}
==========

This study and previously published findings \[[@R52], [@R55], [@R56], [@R150], [@R151], [@R154], [@R155]\] validate our hypothesis on the existence of three different mechanisms through which PE21 can delay yeast chronological aging and extend yeast longevity. This hypothesis is described in the Results section and schematically depicted in [Figure 2](#F2){ref-type="fig"}.

We found that PE21 activates these three different mechanisms of aging delay and longevity extension because it instigates specific changes in the concentrations of several lipid classes, as summarized below.

The first mechanism by which PE21 slows aging and extends longevity consists in the ability of PE21 to decrease the intracellular concentration of FFA ([Figure 2](#F2){ref-type="fig"}). This allows PE21 to sustain FFA concentration below the toxic threshold, thus postponing the age-related onset of an FFA-dependent mode of liponecrotic RCD ([Figure 2](#F2){ref-type="fig"}). The commitment of yeast to this mode of RCD in response to excessive FFA concentrations is caused by an augmentation of PM permeability for small molecules, a weakening of mitochondrial functionality, a significant increase in mitochondrial ROS production, an oxidative damage to different types of cellular organelles and the ensuing autophagic degradation of these organelles *en masse*, and an oxidative impairment of many cytosolic proteins that leads to a build-up of the dysfunctional, unfolded and aggregated forms of these proteins \[[@R32], [@R52], [@R137], [@R150]--[@R155]\]. Because PE21 decreases the risk of aging-associated liponecrotic RCD and increases the chance of elderly cells to survive, it decelerates chronological aging and prolongs longevity of *S. cerevisiae*.

The second mechanism through which PE21 delays aging and expands longevity consists in its ability to decrease the concentration of TAG and to increase the concentrations of all glycerophospholipid classes (i. e. PA, PC, PE, PI and PS) within the ER membrane ([Figure 2](#F2){ref-type="fig"}). These PE21-dependent perturbations in the abundance of ER membrane lipids activate the UPR^ER^ system ([Figure 2](#F2){ref-type="fig"}). The PE21-dependent activation of the UPR^ER^ system promotes chaperone-assisted protein folding and assembly within the ER, *N*-linked protein glycosylation in the ER, the ubiquitin/proteasome-dependent degradation of improperly folded proteins in the ER, vesicular protein traffic from the ER to the Golgi apparatus, glycerophospholipid synthesis within the ER, and the reparation of oxidative damage to proteins and lipids in the cytosol and mitochondria. The PE21-dependent activation of the UPR^ER^ system also suppresses ribosome assembly, tRNA synthesis and protein translation in the cytosol; such suppression is known to delay aging and extend longevity in evolutionarily distant eukaryotes \[[@R28], [@R30], [@R230]--[@R254]\]. All cellular processes that are promoted or suppressed by the PE21-inducible UPR^ER^ system are indispensable for the ability of PE21 to slow yeast chronological aging because they allow to decelerate an age-related decline in protein and lipid homeostasis and to delay an aging-associated deterioration of cell resistance to oxidative and thermal stresses.

The third mechanisms underlying aging delay and longevity extension by PE21 consists in the ability of PE21 to increase PS and PE concentrations and to decrease CL concentration in the mitochondrial membranes ([Figure 2](#F2){ref-type="fig"}). These PE21-driven changes in the mitochondrial membrane lipidome alter mitochondrial functionality because they cause an upregulation or downregulation of many mitochondrial proteins, thereby reorganizing vital processes confined to mitochondria. Mitochondrial proteins that are upregulated in response to PE21 include components of the ETC and OXPHOS, enzymes that catalyze the TCA and glyoxylate cycles, proteins involved in ROS detoxification and oxidative stress protection, proteins implicated in the synthesis of heme and its attachment to other proteins, chaperones that assist in the folding and refolding of other proteins, and components of the mitochondrial protein import machinery. Among mitochondrial proteins that are downregulated in response to PE21 are components of the mitochondrial division (fission) apparatus as well as proteins implicated in mitochondrial RNA synthesis, processing and translation. All mitochondrial processes that are upregulated or downregulated by PE21 play essential roles in the PE21-dependent delay of yeast chronological aging because they allow to amend the pattern of age-related changes in mitochondrial respiration, mitochondrial membrane potential and mitochondrial ROS production \[[@R55]\].

The challenge for the future is to define mechanisms underlying the PE21-dependent remodeling of the ER and mitochondrial membrane lipidomes in chronologically aging yeast. Because PE21 slows aging by inhibiting a form of the pro-aging protein kinase Sch9 that is activated by the pro-aging PKH1/2 signaling pathway \[[@R56]\], one could envision that these mechanisms may involve certain changes in the reversible phosphorylation of proteins implicated in lipid metabolism and transport in the ER and mitochondria. Our ongoing studies address the validity of this assumption.

MATERIALS AND METHODS {#s4}
=====================

Yeast strains, media and growth conditions {#s4_1}
------------------------------------------

The wild-type strain *Saccharomyces cerevisiae* BY4742 (*MAT*α*his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0*) and single-gene-deletion mutant strains in the BY4742 genetic background (all from Thermo Scientific/Open Biosystems) were grown in a synthetic minimal YNB medium (0.67% (w/v) Yeast Nitrogen Base without amino acids from Fisher Scientific; \#DF0919-15-3) initially containing 2% (w/v) glucose (\#D16-10; Fisher Scientific), 20 mg/l *L*-histidine (\# H8125; Sigma), 30 mg/l *L*-leucine (\#L8912; Sigma), 30 mg/l *L*-lysine (\#L5501; Sigma) and 20 mg/l uracil (\#U0750; Sigma), with 0.1% (w/v) PE21 (Idunn Technologies Inc.) or without it. PE21 is an ethanol/water extract from the bark of *Salix alba* \[[@R55]\]. If added to growth medium at the time of cell inoculation at a final concentration of 0.1% (w/v), PE21 increases both the mean and maximum chronological lifespans of wild-type strain cultured in medium initially containing 2% (w/v) glucose \[[@R55]\]. A 20% stock solution of PE21 in ethanol was made on the day of adding this PE to cell cultures. The stock solution of PE21 was added to growth medium with 2% (w/v) glucose immediately following cell inoculation into the medium. In a culture supplemented with PE21, ethanol was used as a vehicle at the final concentration of 0.5% (v/v). In the same experiment, yeast cells were also subjected to ethanol-mock treatment by being cultured in growth medium initially containing 2% (w/v) glucose and 0.5% (v/v) ethanol. Cells were cultured at 30° C with rotational shaking at 200 rpm in Erlenmeyer flasks at a "flask volume/medium volume" ratio of 5:1.

Mass spectrometric identification and quantitation of cellular lipids {#s4_2}
---------------------------------------------------------------------

Extraction of cellular lipids and their mass spectrometric identification and quantitation were performed as previously described \[[@R7]\]. Briefly, a sample of cells was taken from a culture on a certain day of culturing. A fraction of the sample was diluted to determine the total number of cells using a hemocytometer (\# 3200; Hausser Scientific). 5 × 10^7^ cells were harvested by centrifugation in a Centra CL2 clinical centrifuge for 5 min at 3,000 × g at room temperature. The cell pellet was washed once in ice-cold nanopure water and once in ice-cold 155 mM ammonium bicarbonate (pH 8.0), and the cells were harvested by centrifugation at 16,000 × g for 1 min at 4° C. The cell pellet was stored at --80° C until lipid extraction. For lipid extraction, the pelleted cells kept at --80° C were thawed on ice before being resuspended in 200 μl of ice-cold nanopure water. The re-suspended sample was transferred to a 15-ml high-strength glass screw top centrifuge tube with a Teflon lined cap (\#0556912; Fisher Scientific). The volume of each sample was topped off to 1 ml with ice-cold nanopure water. To each tube the following was added: 20 μl of the internal standard mix prepared in Chromasolv HPLC (\>99.9%) chloroform (Sigma-Aldrich) as described \[[@R7]\], 800 μl of 425--600 μM acid-washed glass beads to break open the cells (\#G8772; Sigma-Aldrich) and 3 ml of a Chromasolv HPLC (\>99.9%) chloroform-methanol mixture (both from Sigma-Aldrich) at a 17:1 ratio. The samples were then vortexed vigorously for 2 h at 4° C and subjected to centrifugation in a Centra CL2 clinical centrifuge at 3,000 × g for 5 min at room temperature. The lower organic phase was then transferred to another 15-ml high-strength glass screw top centrifuge tube using a glass Pasteur pipette with careful attention not to disrupt the glass beads or upper aqueous phase. 1.5 ml of chloroform-methanol (2:1) solution was added to the remaining upper aqueous phase. The samples were again vortexed vigorously at 4° C for 2 h. The initially separated organic phase was kept at 4° C for the duration of the second vortexing. At the end of 2-h vortexing, the samples were again centrifuged for 5 min at 3,000 × g at room temperature; the lower organic phase was then separated and added to the corresponding initial organic phase with a glass Pasteur pipette. With both lower organic phases combined, the solvent was evaporated off by nitrogen gas flow. Once all solvent was evaporated, the remaining lipid film was dissolved in 100 μl of chloroform-methanol (1:2) and immediately transferred into 2-ml glass vials with Teflon screw tops to avoid evaporation until samples were analyzed by mass spectrometry (MS). Samples were then stored at --80° C and ran on the LTQ Orbitrap Mass Spectrometer within one week of the extraction. Samples were diluted (1:1) with chloroform/methanol (1:2) mixture supplemented with 0.1% ammonium hydroxide. Lipids were resolved by direct injection using a Thermo Orbitrap Velos mass spectrometer equipped with a HESI-II ion source (Thermo Scientific, Waltham, MA, USA) at a flow rate of 5 ml/min. The optimized tune setting and instrument methods for mass spectrometric analysis of lipids were previously described \[[@R7]\]. Mass spectra were converted to open format mzXML using the ProteoWizard MSConvert software (<http://proteowizard.sourceforge.net/>), the file format used by the Lipid Identification Software LipidXplorer (<https://wiki.mpi-cbg.de/lipidx/Main_Page>) for the automated detection and quantitation of lipid species. Data were normalized by taking the ratio of signal intensity of precursor ions to that of their respective lipid class-specific internal standard (spiked standard), multiplied by the concentration of that standard to give a molar quantity.

Total cell lysates preparation {#s4_3}
------------------------------

Total cell lysates were made by vortexing the cells in TCL buffer (25 mM Tris/HCl pH 8.5, 150 mM NaCl, 1 mM EDTA, 0.1 mM dithiothreitol \[DTT\], 4% CHAPS, 1 mM PMSF, protease inhibitor cocktail \[\#P8340; Sigma\]) with glass beads three times for 1 min. Lysates were then centrifuged for 3 min at 21,000 × g at 4° C and supernatants collected.

Mass spectrometric identification and quantitation of cellular proteins {#s4_4}
-----------------------------------------------------------------------

SDS-PAGE of cellular proteins was performed as previously described \[[@R255]\]. Protein bands stained with QC Colloidal Coomassie Blue were cut out from an SDS-PAGE gel with a razor blade. The gel pieces were placed in individual 0.5-ml siliconized Eppendorf tubes. The bands were destained by washing twice with distilled water for 1 h. The bands were then incubated in 50 μl of acetonitrile (ACN) for 5 min at 37° C, after which ACN was removed and the bands were dried at 37° C. Next, the destained bands were incubated in 50 μl of 10 mM DTT for 30 min at 37° C to reduce thiol groups in peptides. DTT was discarded and the bands were incubated in 50 μl of 55 mM iodoacetamide (IAA) for 20 min at 37° C in the dark to remove the residual DTT. IAA was removed, and the bands were incubated in 50 μl of a 1:1 mixture of 100 mM ammonium bicarbonate (ABC) and 50% acetonitrile for 10 min at 37° C. The mixture was discarded, and the bands were incubated twice in 50 μl of ACN under the same conditions and dried at 37° C. The trypsin and trypsin buffer were prepared as follows: 1) 1.6 ml of a 1:1 mixture of 100 mM ABC and 10mM CaCl2 were used to resuspend 20 μg of trypsin; and 2) for protein digest, 50 μl of trypsin solution (1 mg/ml) was added to the bands, which were then incubated overnight at 37° C. The following day, the samples were spun down and the supernatants containing peptides were transferred to new 0.5-ml siliconized Eppendorf tubes. To extract more peptides, the gel pieces were subjected to several washes and treatments at room temperature; the supernatants were conserved and combined with the first set to extracted peptides. For the first extraction, the bands were initially incubated in 50 μl of 25 mM ABC for 10 min and then in 50 μl of ACN for 10 min. The samples were spun down, and the supernatant were added to the first set of extracted peptides. For the second extraction, the bands were incubated in 50 μl of 5% formic acid for 10 min and then in 50 μl of ACN for 10 min. The samples were spun down, and the supernatant were combined with the first set of extracted peptides. The gel pieces were no longer used and discarded. To prevent possible oxidation during storage, 12.5 ml of 100 mM DTT was added to each set of peptides. The peptides were completely dried in a Speed-Vac at medium temperature settings (37° C) for 2 h and stored at --20° C until MS analysis. Dried peptides were resuspended in 20 μl of 5% ACN. For each recovered protein band, an aliquot of 10 μl of dried peptides in 5% ACN was diluted 2-fold in nanopure water for MS analysis. Samples can be stored at --20° C until being subjected to MS analysis. Individual proteins composing each band were then identified by reverse phase high performance liquid chromatography coupled to mass spectrometry (RP-HPLC/MS) using an LTQ Orbitrap. 3-μl aliquots of peptides were separated in ACN gradient using a 100-μM capillary column packed with C18 mobile phase. Once acquiring time was completed using the LTQ Orbitrap, the raw mass spectrometry data file obtained by Xcalibur were analyzed using the Thermo Scientific Xcalibur Proteome Discoverer application (version 1.3) hereafter referred to as the Proteome Discoverer. The Proteome Discoverer was used to identify individual proteins by comparing the raw data of mass spectra of digested fragments to the mass spectra of peptides within the Uniprot FASTA database. The analysis by the Proteome Discoverer coupled to the FASTA database was enabled by using the peak-finding search engine SEQUEST. The SEQUEST engine processes MS data using a peak-finding algorithm to search the raw data for generating a peak probability list with relative protein abundances. The "Proteome Discoverer" software was used to calculate the exponentially modified protein abundance index (emPAI), a measure of the relative abundance of cellular proteins in a pair of analyzed datasets.

Chronological lifespan assay {#s4_5}
----------------------------

A sample of cells was taken from a culture at a certain day following cell inoculation and PE21 addition into the medium. A fraction of the sample was diluted to determine the total number of cells using a hemacytometer. Another fraction of the cell sample was diluted, and serial dilutions of cells were plated in duplicate onto YEP medium (1% (w/v) yeast extract, 2% (w/v) peptone; both from Fisher Scientific; \#BP1422-2 and \#BP1420-2, respectively) containing 2% glucose (\#D16-10; Fisher Scientific) as carbon source. After 2 d of incubation at 30° C, the number of colony forming units (CFU) per plate was counted. The number of CFU was defined as the number of viable cells in a sample. For each culture, the percentage of viable cells was calculated as follows: (number of viable cells per ml/total number of cells per ml) × 100. The percentage of viable cells in mid-logarithmic growth phase was set at 100%.

Cell viability assay for monitoring the susceptibility of yeast to a mode of cell death induced by palmitoleic acid (POA) {#s4_6}
-------------------------------------------------------------------------------------------------------------------------

A sample of cells was taken from a culture on a certain day of culturing. A fraction of the sample was diluted to determine the total number of cells using a hemocytometer. 8 × 10^7^ cells were harvested by centrifugation for 1 min at 21,000 × g at room temperature and resuspended in 8 ml of YP medium containing 0.2% glucose as carbon source. Each cell suspension was divided into 8 equal aliquots. Three pairs of aliquots were supplemented with POA (\#P9417; Sigma) from a 50-mM stock solution (in 10% chloroform, 45% hexane and 45% ethanol; \#650498, \#248878 and \#34852, respectively; all from Sigma). The final concentration of POA was 0.05 mM, 0.1 mM or 0.15 mM for each pair of aliquots; in all these aliquots, the final concentrations of chloroform, hexane and ethanol were 0.03%, 0.135% and 0.135%, respectively. One pair of aliquots was supplemented only with chloroform, hexane and ethanol added to the final concentrations of 0.03%, 0.135% and 0.135%, respectively. All aliquots were then incubated for 2 h at 30° C on a Labquake rotator (\#400110; Thermolyne/Barnstead International) set for 360° rotation. Serial dilutions of cells were plated in duplicate onto plates containing YP medium with 2% glucose as carbon source. After 2 d of incubation at 30° C, the number of colony forming units (CFU) per plate was counted. The number of CFU was defined as the number of viable cells in a sample. For each aliquot of cells exposed to POA, the % of viable cells was calculated as follows: (number of viable cells per ml in the aliquot exposed to POA/number of viable cells per ml in the control aliquot that was not exposed to POA) × 100.

Fluorescence microscopy {#s4_7}
-----------------------

Propidium iodide (PI; \#P4170, Sigma) staining for visualizing the extent of plasma membrane permeability for small molecules \[[@R256]\] and Annexin V (\#A13201; Thermo Fisher Scientific) staining for visualizing externalized phosphatidylserine \[[@R256]\] were performed according to established procedures. Live imaging was performed on a Leica DM6000B epifluorescence microscope equipped with a high-resolution Hamamatsu Orca ER CCD camera using oil immersion and a 100× objective. Images were acquired with 20-ms exposures using PerkinElmer Volocity software. Image files were exported as TIFFs then opened in ImageJ, where the percentage of PI- and Annexin V-positive cells was calculated.

Statistical analysis {#s4_8}
--------------------

Statistical analysis was performed using Microsoft Excel's (2010) Analysis ToolPack-VBA. All data on cell survival are presented as mean ± SEM. The *p* values for comparing the means of two groups using an unpaired two-tailed *t* test were calculated with the help of the GraphPad Prism 7 statistics software. The logrank test for comparing each pair of survival curves was performed with GraphPad Prism 7. Two survival curves were considered statistically different if the *p* value was less than 0.05.

SUPPLEMENTARY MATERIALS {#s5}
=======================
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Ac-CoA

:   acetyl-CoA

ACN

:   acetonitrile

ADHAP

:   acyl-dihydroxyacetone phosphate

AMPK

:   AMP-dependent protein kinase

ATG

:   autophagy

CDP

:   cytidine diphosphate

CFU

:   colony forming units

CL

:   cardiolipin

CLS

:   chronological lifespan

CR

:   caloric restriction

DAG

:   diacylglycerols

DTT

:   dithiothreitol

emPAI

:   exponentially modified protein abundance index

ER

:   endoplasmic reticulum

ETC

:   electron transport chain

FA-CoA

:   fatty acyl-CoA esters

FFA

:   free (unesterified) fatty acids

IAA

:   iodoacetamide

IGF-1

:   insulin/insulin-like growth factor 1

IMM

:   inner mitochondrial membrane

IMS

:   intermediate space

L

:   logarithmic growth phase

LD

:   lipid droplets

LPA

:   lysophosphatidic acid

MAG

:   monoacylglycerols

MS

:   mass spectrometry

mTORC1

:   mammalian target of rapamycin complex 1

OMM

:   outer mitochondrial membrane

OXPHOS

:   oxidative phosphorylation

PA

:   phosphatidic acid

PC

:   phosphatidylcholine

PCA

:   principal component analysis

PD

:   post-diauxic growth phase

PE

:   phosphatidylethanolamine

PG

:   phosphatidylglycerol

PI

:   phosphatidylinositol

PKA

:   protein kinase A

PKH1/2

:   Pkb-activating kinase homolog

PM

:   plasma membrane

POA

:   palmitoleic acid

PS

:   phosphatidylserine

RCD

:   regulated cell death

ROS

:   reactive oxygen species

RP-HPLC/MS

:   reverse phase high performance liquid chromatography coupled to mass spectrometry

SNF

:   sucrose non-fermenting

ST

:   stationary growth phase

TAG

:   triacylglycerols

TCA

:   tricarboxylic acid

UPR^ER^

:   unfolded protein response in the endoplasmic reticulum

WT

:   wild type

YNB

:   yeast nitrogen base
